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It is truthfully said that, until recent years, 
the care and treatment of the insane has been sadly 
neglected. Insanity was considered as a divine punish-
ment even as late as the nineteenth century, and it 
has only been within recent years that the true sig-
nificance of mental disea~e as a medical problem has 
been realized. 
During the last deoade we have witnessed an 
epoch in psychiatric therapeusis. Numerous methods 
have been advanced as adjuncts to the treatment of 
the functional mental patient. The efficacy of these 
methods has given new impetus to research, and although 
these methods are rapidly becoming legion, it is not 
to be inferred that they are at present exhaustive. 
In the first section of this paper a resume of 
the history of the early oare of the insane, of both 
organic and functional origin, is included. This is 
followed by a discussion of the institutional care of 
the mentally ill, including a discussion of recently 
advocated institutional methods. 
The remaining sections are devoted to a review of 
the literature relative to recent methods of the applic-
ation of drugs as therapeutic adjuncts in the treatment 
qg10G9 
of funotional mental patients. As this paper is limited 
to a aonsideration of drug therapy, mention of the 
recently advooated prefrontal lobotomy method of treat-
ment is not inaluded. Partioular emphasis has been 
plaoed upon the teahnic of the application of these 
drugs. It is not the author's intention to infer that 
these more recent methods may supersede the methods of 
treatment already in use, including psychotherapy, 
oaoupational therapy, recreational therapy. and many 
others. However, these more reoent methods may serve 
as a valuable adjunct when used as a supplement to 
the already existing forms of therapy. 
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I.N!BODUOTION 
It has been reliably estimated that of the seven 
thousand infants born each day in the United States 
about two hundred and seventy, or one in twenty six, 
eventually become incapacitated by abnormalities of 
the mind.(l) Likewise, it is known that approximately 
76,000 new patients are annually admitted to state 
institutions for the insane with a total of 147,621 
new patients admitted yearly to all institutions oar-
ing for the insane in the United States.(1,2) Of the 
total 808,445 available hospital beds in the United 
States, the mental group constitutes 445,867 or fifty 
five per oent of the whole.(2) 
Strecker (1) lists the inoidenoe of the psyohoets 
as follows: 
Dementia Praecox--------------------27.~ 
~io Depressive---•----------------12.9~ 
Involutional Melancholia------------ 3.0% 
Paranoia----~-~----~-------~-------~ •5% 
Psychoneurosis---------------------- 2.4~ 
Thus the pe7ohosts and neuros•s constitute forty six 
per oent of all mental disease. He further states that 
it is conservatively estimated that between si:rt7 five 
and seventy five per oent of the psyohosts which are comp-
arable to what the internist would designate ''acute" are 
recoverable• 
1 
:B'llnotional psyohoses include all psychoses in which 
oonstant organic and toxic factors have not been ascertain-
ed. 
This paper is confined to a consideration of the 
treatment of functional mental disease. An attempt is 
made to depict the hi~tory of therapy and institutional 
oare of these patients. Emphasis has been placed upon 
the present status of hospital care and upon the technic 
of reaent therapeutic methods. 
The therapeutic methods considered have been restrict-
ed to medical (drug) therapy. The~e drugs are considered 
in the following sequence: history, selection of patients, 
technic of administration of therapeutic agents, reactions, 
complications of treatment, results, and clinical and 
laboratory findings. It is acknowledged that therapy is 
predominantly empirical, but wherever rationale has been 
proffered, it will be included. 
No '!!)ace he,~ be~n devoted to a review of the etiol-
ogy of the~e conditions, and psycho-therapeutic and 
surgical methods have been intentionally omitted. 
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' HISTORY 
"J'oul whisperings are abroad: unnatural deede 
Db breed unnatural troubles: infected minds 
To their deaf pillows will discharge their seorets. 
More needs she the divine than the physician-" 
Shake spear• 
The distinction between those mentally and those 
phyeioally 111 is of extreme antiquity. In the earliest 
historical records we find that insanity was referred to 
as possession of the body by demons and evil spirits 
and, but more rarely, to the favor of the gods. This 
belief has persisted until comparatively recent times. 
Dorcas and Shaffer (3) state that an Egyptian 
papyrus dating abou• three thousand B. c. ha.a been 
discovered in whioh is set forth the proceedings of 
modern hypnotism. They state that the Medea, Obaldeans. 
and Indians were very familiar with the hypnotic state, 
and that the methods have probably been handed down 
through the prieste of Egypt, The Persian Magi and the 
Levites. These authors sugge~t that the temple sleep 
induced by the priests was likely hypnotic. 
Naturally the idea of demonological possession 
easily opened the way for flagrant abuses in the treat-
ment of the insane. They were poorly sheltered, scantily 
fed, unolotbed, chained, tortured. burned and beaten, 
all in an effort to drive out the demons.(1,4) 
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Streaker (l) states that the only interruption of 
this primitive point of view was tbe rational belief of 
the great Hippoorates (460-375 B. o. ) and other Greeks 
of that period, who taught that "the brain is the organ 
of the mind." 
Asolepiades of Bitbynia (124 B. o. ) was tbe first 
pioneer in the humane treatment of mental disorders, 
indeed as lriedreioh observes "first taught us how to 
treat the insane." He noted that the frenzied patient 
has hallucinations whe~eas the maniaoal patient ha• 
delusions. Reasoning that hallucinations are exaggerated 
in the dark, he discarded the antique praotioe of keep-
ing mental sufferers in the dark by letti:ng in broad 
dayl~ght. For treatmnet he employed occupational therapy, 
' 
exercises in promoting memory and fixing attention, 
music and wine to promote sleep.(5) 
Tulce (6) states that among our Saxon anoestora 
(sixth century) the treatment of the insane was a curious 
compound of pharmacy, superstition and castigation. 
Demoniacal possession was fully believed and.as is well 
known,exoroism was practioed by the Ohruoh as a reoognised 
ordinance. He states that it appears that the Saxon 
leeches derived much of their knowledge directly from 
the Romans and through them from the Greeks. 
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He cites from a collection of articles entitled 
"Leeohdoms, Wortounning and Staroraft of Early England" 
(:Medicine, Herb Treatment and Astrology) rmmerous methods 
employed by these Saxon leeches. 
The directions for a "fiend sick man" were as follows. 
"Take a spew-drink, namely lupin bishopwort, henbane, 
cropleek. Pound them together; addale for a liquid, let 
it stand for a night and add fifty liboorna (seeds of 
Wild saffron) or cathartic grains and holy water." 
"Another mixture compounded of many herbs and of 
clear ale was to be drunk out of a church bell (acolytes' 
bell) while seven masses were to be sung over the worts 
or herbs, and the lunatic was to sing psalms, the priest 
saying over him Domine, sanote pater omnipotens~ 
Mandrake administered in a draught of warm water was 
prescribed for witlessness; and periwinkle (Vinca pervinca) 
was regarded as of great advantage for demoniacal possesa-
ion and "various wishes". Directions included were, "When 
thou shalt pluok this wort, thou shalt be clean from every 
uncleanliness and thou shalt pluck it when the moon is 
nine nights old and eleven nightg and thirteen nights and 
thirty nights and when it is one night old." 
Wolf's flesh.well dregsed and sodden was to be eaten 
by a man troubled by hallucinations. 
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Other directions included, "In oase a man be 
lunatic take a skin of mere swine (sea pig or porpoise) 
work it into a whip, and swinge the man therewith; soon 
he will be well. Amen." 
Tuke states that bowsening (ducking) was also 
practiced. In support of this statement he cites the 
following description from "Leeohdoms, Wortounning and 
Starcraft of Early Eneland." "A ~tronge felloW., provided 
for the nonce tooke him and tossed him up and downe 
alongat and athwart the water untill the patient by 
forgoing his strength had somewhat forgot his fury. "The 
patient was then conveyed to the ohuroh and certain masses 
sung over him. If there appeared small amendment he was 
bowsened "againe and againe while there remayned in him 
al'J1' hope of life for recovery." 
Bartholomew the ~nglisbman (Bartholomaeua Anglious) 
writing in the middle of the thirteenth century was a 
proponent of the humane treatment of the insane. He states,· 
"The medicine of them is, that they be bound, that they 
hurt not themselves and other men. And namely. suoh shall 
be refreshed. and comforted, and withdrawn from the cause 
and matter of dread and busy thoughts. And they must be 
gladded with instruments of music, and some deal be 
occupied." ( 7) 
We may oonolude that the early history of the oare 
of the insane was predominantly barbaric with little or 
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no soientifio approach and with ~ew advocates of humane 
treatment. 
These conditions persisted throughout the Middle 
Agee. Streaker (l) states that this state of affairs 
existed even during the nineteenth century. Haggard (4) 
relates that the medieval Christians built hospitals and 
everyone who was physically ill wa~ admitted. Ther insane 
were exoludad. He states, "the insane, and the devils 
whioh were supposed to possess them, were ohained in 
madhouses, plaoes even worse than the prisons of thoae 
days. There they remained poorly sheltared, scantily fed 
and unclothed to lie in their own excreta until they 
died of neglect and exposure. The only treatmant they 
received was an occasional beating when their oriee 
became annoying." 
In non-Christian countries during medieval times the 
oare of the insane was muoh better. In Arabia they were 
treated kindly and were kept in asylums where their Oriental 
love of hearing stories was U9ed to keep them quiet. 
It was during the Middle Ages that institutionalizat-
ion o:f mental :patients was inaugurated. LL:ewise a new 
impetus to the humane treatment of the insane resulted 
from the efforts of Philippe Pinal. 
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IlfSTITUTIONS 
l!.ilropean 
The earliest insane asi\iuns in the northern oountries 
were St. Mary of Bethlehem or "Bedlam" in London (1547), 
the Julusspital at Wurtzburg (1567), St. Lukes in London 
(1751), the Quaker or Oountry Asylum near York (1792), 
and the Narrenthurm or "Lunatios Tower" in Vienna (1784) • 
Du.ring the eighteenth oentury Bedlam was one of the 
"sights" of London and the public were allowed to view 
the insane like animals in a menagerie on P8JTII1Gnt of a 
small fee. Samuel Johnson and Boswell visited Bedlam 
and Steele took three school boys to see "the lions, the 
Tombs, Bedlam and other places which are entertain-
ment to raw minds, beoause they strike forcibly on the 
imagination." (4,5) 
It is states that the oonditions in Bedlam fully 
justified the significance wbioh the word "bedlam" 
aoquired. 
The "open door" system was praotiood at Bedlam. 
That is, the patients, after they had recovered from 
their primary attack, were allowed to go out wearing a 
plate on their arm wh1oh indioated that they had been 
in Bedlam for a time. John Aurbre7 wrote, "!ill the break-
ing out of the Civil War. Tom of Bedlam9 did travel about 
the oountry---thay had on their left arm an armilla of 
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tin about four inches long; they could not get it off. 
They wore about their necks a great horn of an ox in a 
string or baudry whioh when they oame to a house for alms 
they did wind, and they did put the drink given them into 
the horn whereto they did put the stopple." Perhaps Edgar 
in Shakespeares "King Lear" refers to this oustom of 
drinking from the horn when he says: "Poor Tom thy horn 
is dry." These Bedlamers, as they were called, were oared 
for more S7JI1pathetically than while they were inmates of 
the hospital. In faot, they were cared for so well by 
the people that "sturdy vagrants", tramps as we would 
call them, would steal these plates or obtain possession 
of them after the death of the wearer and use them for 
imposition upon the people.(4,5,,) 
However, the welfare of those confined within the 
various asylums was less fortunate. Hospital management 
ws.~ deplorable and living conditions were e•en worse. 
Lunatics Tower, where as in ancient Bedlam, visitors 
came to be amused at the antics of the imnates,was 
4escribed in 1815 as a "fanoiful, four story edifioe 
having the external appearance of a large round tower, 
but consisting on the inside of a hollow circle in the 
center of which a quadrangular building arose joined to 
the oirole by eaoh of its oorners. The enclosed structure 
9 
afforded reeidenoe for the keepers and surgeons. The 
oiroula.r part contained three hundred patients."(5) 
The patients were either chained or caged when housed 
or if harmless were allowed to run at large. the 
"wizards and warlooks"of Scotland. Lunatics Tower was 
not closed until 1853. 
Garrison states that until well into the nineteenth 
century insanity was regarded as not only unourable but 
as a disgraoe rather than a misfortune. Heinroth (1818) 
even regarded it as a divine punishment for personal 
guilt of some kind. In the later asylums including those 
erected at Munich (1801). Sonnenstein (1811), Beigburg 
(1815) and Saohsenburg (1830) the "sad lot of the insane 
was that of Hogarths engraving and Kaulbaohs celebrated 
drawing."(5) 
Monkemollers researches on German psychiatry in the 
eighteenth century confirm what Reil wrote of German 
asylums in his "Rhapsodies" (1803) and go to show that 
the theoretic part of the science was nebulous philoeophio 
speculation. 
Little progress in therapy was made at this time. 
A medical book written at the time Bedlam was opened 
summarizes the accepted treatment of the insane--"! 
do advertyse every man whioh is madde or lunatyche or 
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frantyoke or de~olly'aoke to be kept in safe garde in 
some olose houae or oha.mber where there is lytell light; 
and that he have a keeper the whioh the madde man do 
fear." (4,5) 
During the seventeenth and eighteenth centuries 
the only oases treated were of the dangerous unmanageable 
or suicidal type and no hope of recovery was held out. 
There was an unoonditiunal belief in the effioaoy of 
drugs, and oases that failed to react ware regarded as 
hopeless. Opium was prescribed for melancholia, camphor 
for excited states, and diaphoresis for pruritis. A 
mysterious power was ascribed to belladonna; if it failed, 
everything failed. Numerous other remedies including 
a mixture of honey and vinegar, a deaootion of Quaden-
wurgel, tartarus tartaresa~us, aqua benediota Rolandi, 
and large quantites of lukewarm water were used. 
Nu~erous procedures as veneseotion of the forehead and 
both thumbs, a mustard plaster on the head, and elysters 
of Spanish fly were other re~ouroes. (5) 
A melancholic woman was treated with a volley of 
oaths and a douche of oold water. Li~ewise marriage was 
reoomanded as a cure. Purgatives and emetics were used 
to control violent patient9, and if this failed they 
reoeived many hard knocks with bolts and chains to 
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inspire their fear. The diet was of the cheapest consist-
ing of soup, warm beer, a few vegetables and salad. There 
were some attempts of open-door treatment such as putting 
the patients to mind geese or sending them as harvest 
hands to Holland. On the whole the brutalities of earlier 
times were ameliorated but the insane were still treated 
.harshly. They were dosed with drugs, bled excessively, 
looked up in cold, dark cells and restrained with ohains. 
( 5) 
The Quaker Retreat, founded by William Tu1::e in 1794 
at York, England , wa9 the first attempt at humane treat-
ment of the insane. (5) However, the first infleuntal 
champion of more gentle treatment of the insane was 
Phillipe Pinel (1745-1836) a physician at the Hospital 
Bicetre of Paris. It is stated that his incentive was the 
death of a friend who had escaped from an asylum and had 
been killed in the forrest by wolves. (4) On 118.y 24, 1798 
with the consent of the National Assembly Pinel struck 
off the chains from fort7 nine patients at Bioetre, as 
depicted in the painting of Tony Robert Pleury. He plao$d 
these patients under lenient physicians, provided whole-
some food and sunlight, and did away with the abuses of 
drugging and blood letting to which they had been subject-
ed. The patients improved and these procedures were 
gradually adopted by the other institutions. In 1856 
the "Treatment of the Insane without Mechanical Restraints" 
by John Oonolly was published. 
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I!{STITUTIONS 
Amerioan 
Prior to 1850 there were a few private insane 
asylums in the United States, but most insane patients 
were confined in oount7 poor houses or prisons. Misa 
Dorothea Dix spread the ideas of Pinel widel7 in this 
oountry and was instrumental in establishing as many.as 
thirty two state asylums. In 1894 Dr. Weir Mitohell 
pointed out the evils of political control and the 
absolute laok of soientifia study of insanity in 
Amerioa. Until the advent of the twentieth aentury the 
oharge that the insane asylums were not hospitals where 
the mentally ill were treated, but were sanatoria where 
they were kept was ~robably justifiable. (8) 
Grimes (2} states that there are in the United 
States six hundred and thirty one hospitals and other 
institutions oaring for the mentally ill and t~e 
mentally deficient. They have a total rated oapacity of 
427,343 and they report a total patient population of 
445,867. They admitted a total of 147,621 patients and 
discharged 83,794; there were 34,089 others who died 
in the institutions. These 631 institutions employ the 
full daily service of 2,337 physiiians, 7,339 nurses and 
38,790 attendants, as well as several thousand other 
13 
workers in various oapaoities. 
Of the 631 institutions, 351 are owned and controlled 
by governmental agencies including federal, state, county 
and city governments; the other 280 are owned and controll-
ed by private agencies including ohurohee, independent 
associations, partnerships and individuals. 
Of the 351 publicly or governmentally controlled, 
251 are state institutions, nearly all of them of huge 
pt"oportions. They contain 85% of all mental patients 
now in institutions; they reoeive 69% of all patients 
admitted to institutions annually. 
Grimes Ce) reporting in 1933 states that ten new 
state hospitals have been built in the last five years 
and eighty three have added to their bed capacity in 
the last five yea.rs. 
From the 631 institutions for mental patients it 
was learned by special que9tionaires that their patient 
population actually exceeded their capacities by 18,524. 
While the total patient population of all hospitals 
and related institutions was 808,445, the total populat-
ion of the mental group alone a.mounted to 445,867 or 
55~ of the whole. The table on the following page 
aummarizeg the findings of Grimes survey. 
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Ins ne 174 2'161436 299 88 689 25~81 l 46 
F. Minded '65 65699 6 44 246 
t1o 11 1 106 10 60 
,, 
l 122 86 149 33 l 115 
76 35867 04 13,055 7.532 44 ]J579 
20 1~489 1~'10 .. 6,293 A.686 406 l.3'71 
4 83, 100'7 458 238 311 
40'7,160 42~963 219'74 12~ 86 63})4' 32,651 26,608 
280 * 56 
I"" PRIVATE INSi'ITUTIONS 
12 2 382 2 193 
6 * 
6 159 48 
280 20 83 15 904 
631 29~64 
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PUBL Q INS! fUTIOB 
198 ~:120 650 
209.0 48 ~- 3,8 266 
Dl11 426.0 a 8 42 
388.0 109 208 1'15. 
43.0 237 636 19 2,161 6 2."l.f. 
INSTITUT. li6.0 32 28 190 791 'I 
!OT.AL OOV! 222.0 1 93'/ 2 905 148 35 238 1 • 
PlIVATE INS!ITU!IONS 
108 408 5.4 569 3.8 
256 5ZO 16.7 2,432 3.6 
' 0 
IQ 128 13.7 
10 29 99.4 
l 2 78.0 
5 9 ·5.3 ' e ··1 
400 06 14.4 ;·:,a ·159 
2 53'1 111.1 
*ATerage oost per patient per day 
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OBE (TH.B AV'.IRAGE) 011' THE 122 STATE 
HOSPITALS PREVIOUSLY MEBTIONED WITH 
A PATIBlIT POPULATION OJ' 1,8'75 
.ADllITS 582 PATIENTS 
DISCHARGES 310 A.DUALLY 
194 ARE RBOOVERED OB IMPROVED 
!HE BIBE PBIVATE ENDOWED HOSPITALS PREVIOUSLY 
JLENTIONED WITH A PATIENT POPULATION ONLY 175 
IN .EXOESS 011' THIS ONE STATE HOSPITAL 
ADMITS 2,0?4 PATIEit!l'S 
DISCHARGE 2,062 PATIENTS 
l,181 ARE REOOVERID 
OR IMPBOVED 
1'1 
• 
Bead and Beranoy state than an adequate profession-
al staff consists of at lea~t one ph7aioian per ever7 
one hundred fifty patients; one registered nuree per 
every hundred patients; and a nurse or attendant per 
every Dinty eight patiente. (9) 
The oritioism has been made that the patientt 
already retreating from reality, is even more 1solate4 
from reality )7 reason of institutionalization and 
separation from community life.(lO)Likewise it ia said 
tha-- the patient ia taken from an environment in whioh 
he wae unable to adjust and plaoed in one adjusted to 
hi~ reduaed powers of adaption only to be returne4t 
upon reooveryt to the same environment, no better 
equipped to oope with his surroundings than he was upon 
commitment to the inetitution. 
lhile it is true that the individual 18 separated 
from an environment in which he has failed to adjust 
and is placed in one which is plastic in its varioue 
degrees of simplification to fit his reduced power• of 
adaption, the majority of institutions have adopted 
programs of education and ree4uoat1on. 
!he Old Hartford Retreat in Pennsylvania 18 a 
pioneer in this reepeot. In 1931 an attempt was made to 
oonvert this institution into an educational center 
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11'1.th as normal an environment as possible. In aooordanoe 
with this, all1'thing smacking of institutionalisation 
was eliminated. Attention wae concentrated on personnel. 
Attendant• were supplemented by psychiatrio aide who 
were required to have at least a high school education. 
Bduoational measures were instituted. At the present 
time a daily program whioh requires regular hours of 
study is planned for each patient. As hie oondition 
improves he is provided with the opportunity of attend-
ing one of the local business schools. He is instruoted 
in courses that will help him become more efficient in 
hie vocation or that s~art his training and interest in 
a new vocation more suitable to his personality. !hese 
courses are supplied by some of the leading universities 
of th• country. Extension oourses in business, eoonomios, 
finanoee, insurance and government are offered in whioh 
the patient is responsible for his work directly to the 
universit7. Art classes and olasses in costume design~ 
ing and horticulture are also offered. A good library, 
with reoent books in literature,musio, history and with 
current periodicals, is maintained and its use is 
enoouragecl. 
Physical education courses are maintained and train-
ing in golf, swimming, squash and badminton is offered. 
Class inetruot1on is provided for those who have not 
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learned to Pl&.7 br14ge or to danoe. Evenings are devoted 
to sooial tu.notions and amusements including up to date 
moving pictures, plays, oonoerts, danoee and bridge 
praties are proTided. 
Separated from the main hospital building a small 
street of shops, including a beauty parlor and book shop, 
has been ereeted. A dress shop is maintained and a 
fashion show ie held at the beginning of eadh season. 
Patients must make their own selection and purchases 
thus doing away with "dispensing". (10) 
In oonoluding this eeot1on of the institutional 
oa~e of the insane it is appropriate that the applicable 
parts. of the program sponsored by the National Oomillittee 
tor Mental Hygiene be outlined. !he Oommittee tenders 
the following suggestions: 
B. "TJ!"eatment 
1. Provision for earlier diagnosis and 
treatment 
"Out patient departments for mental 
oases in connection with hospitals 
for mental disease• and general 
hospitals and independent of ei~her 
of these agenoi&t 
Provision tor inoipient aad emergenc) 
oases in psychopathic wards of general 
hospitals 
A psychiatric hospital in eaoh of the 
fifty United States cities of more 
than 100,00 population; such hospital• 
to be the centers of practical work 
in prevention and social service as 
well as for efficient treatment 
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2. Improvements in methods of admission 
and ooUBD.itment 
!ransfer of the responsibility for 
the oare of patients pending commit-
ment from overseers of the poor and 
polioe officials to physicians 
Improvement in the legal steps nec-
essary for admission to hospitals 
especially elimination of oourt measures 
whioh often imperil patients chances 
for reoover7 
Extension of the use of the "emergency" 
and "voluntary" comid.tments 
3. State Systems for the publio care of the 
insane and mentally defective 
Establishment of complete state care 
and state supervision of private instit-
utions, under strong central administrat-
ion 
Elimination of politics from state 
institutions; all appointments and 
promotions under strict civil service 
control 
Establishment of after-care and social 
service work under the direction or 
with the full cooperation of state 
institutions 
4. Institutional provisions 
Sanatoriums for early oaBes of mental 
disorders and eepeoially for psyoho-
neruoses 
Hospitals of moderate size in cities 
with facilities for active treatment 
of acute oases 
Oolonies in the oount?7 for more chronic 
oases where patients may be treated in 
small groups under attractive and home 
like surroundings 
5. Special features of treatment 
Increased number of physicians in state 
hospitals and especially provision for 
training young physicians who enter 
this work 
Encouragement of research in many fields." 
(11) 
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IlmI!ATIVJ THERAPY 
noanat thou not minister to a mind diseas'd; 
Pluok from the memor7 a rooted sorrow; 
Raze out the written troubles of the brain; 
A~d with some sweet oblivious antidote 
Oleanse the stuf£'d bosom of that perilous stuff 
Which weighe upon the heart?" 
Sha.leeapeare 
Metraaol 
Metrazol, aooo~ding to American terminology, or 
oardiazol, according to ~"uropean terminolofD', and 
camphor are the two irritative or oonvulsive drugs 
to be considered in this section. 
Botkin, in 1929 oommented on the relative absence 
of convulsive episodes in schizophrenia and in manio-
depressi ve psyohosis.(12) Meduna believing that a 
biologic antagonism existed between epilepsy and aohiz-
o~hrenia, attempted to treat the later by reproducing 
epileptifrom convulsions. In 1935 he utilised metrazol 
. for, this purpose. (13) 
In addition to the treatment of schizophrenia, 
meti'azol has recently been utilized. in the treatment 
of depreseive peyohoeie, including manic-depressive and 
involutional types, ,and in the treatment of the psyoho-
nanroaia. {14,15,16 ,17) 
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Jflduna (13) and Friedman (18,19), Kennedy (20), 
Sorger (21), Reese (22,27) and numerous other authors 
have noticed that the oatatonio type of schizophrenia 
whioh is relatively refraotile to insa.lin therapy shows 
the greatest tendency to remit with metrazol therapy. 
This is olosely followed by the paranoid type of schiz-
ophrenia. Some authors, in fact, maintain that the 
psyohosis with a predominant picture of motor phenomena 
is to be handled with convulsive therapy (metrazol) 
while the peyohosis demonstrating mainly peyobio 
phenomena (hallucinations, delusions) is to be treated 
with insulin. Thie latter supposition is subject to 
dispute. 
Friedman and Meduna (13, 18, 19) olassify contra-
indioations as absolute and relative. Absolute oontra-
indioations of this therapy include; (a) evidence of 
oar41ovasoular disease, (b) aoute febrile infections, 
Co) menstruat~on, (d) pregnancy, (e) severe anemia or 
caohexia, and (f) any abnormality of the blood or 
urinary constituents. Relative contraindications 
include; (a)· exophthalmic goiter, (b} history of severe 
intraoranial 1njur7, Co) seropost1ve syphilis, (d} 
latent tuberculosis, (e) confinement to bed for one year 
before treatment is undertaken. (19) 
In relation to oard1ova9oular disease it is interest-
ing to note that Drs. Bennett and Wright (16) report 
that in eighteen patients reoeiving metrazol therapy the 
original eleotrooardiographio record was unchanged by 
the convulsive therapy. 
Various modifioations of metrazol treatment have 
been described in the literature, but the technique is 
fundamentally the same. :B'riedman (18) divides the 
treatment into two parts. In part A the patient is 
given a thorough physical examination and a complete 
laboratory examination. DUring this time he is placed 
on an alkaline diet sufficient in calories, vitamines, 
and bulk. He is given sodium bicarbonate (1,3 G) three 
times daily. Fluid intake is set at a minimum of two 
liters per day. The urine is tested daily for the 
first five days and following tQ.is is tested twioe 
a week for alkalinity throughout the treatment. Part 
J ooneiste of the actual metrazol regime. 
A ten per oent aqueous solution of.metrazol 19 
used intravenously•. as veins tend to become solerosed 
after a few injeotions of the twenty per oent solution. 
The solution is stable and does not deteriorate with 
time. (17) A twenty per oent solution does not increase 
the inoidenoe of oonvuJ.sions. (22,27) The initial dose 
of metra2ol varies between two and five oc. and therapy 
24 
is oontinued every other day. Finkleman et al (23) 
have given a·good summary of the treatment as follo•s: 
"The treatment is given in the morning when the 
patients stomaoh is empty. The dose is the small• 
est amount of the drug that will produce a typical 
oonvuJ.eive seizure. Our first dose is ranged from 
two to five co. of the ten per cent solution. 
As a rule we administered about one co. for 
about eaoh thirty pounds of body weight but 
not over five oo. for the first dose. Thie dose 
usually produced a convulsion. When the oonvuls-
i ve dose was reached it was maintained until we 
failed to get a reaction. In suoh oases the 
treatment was repeated the next daJ the dose 
being inoreased by one oo. For patienta with 
a longer duration of the psychosis the dose of 
the dwug had to be repeated more often than 
for others. The treatment was admini~tered two 
or three times a week." 
Friedman (18) plaoes the initial dose of metrazol 
at five oo. b'ubsequent doses are increased at the rate 
of one co. every injection irregardless of whether or 
not the convulsions ocour. He eats tbe maximum dose 
at sixteen oo. 
When the dose is 1nsuff1oient to produce a oomplete 
oonvula1on a minimal reaction consisting of mental 
oonfus!on and a few myoolon1o movements occur. ll'riedman 
(18) terms these reaotion• "petit mal reactions". He 
observes that the patient undergoes a restless type of 
gross twitching for one or two seconds and that thia 
1 s immediately :followed by a period of intensely vivid 
hallucinatory reactions lasting for as long as two hours. 
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With a still smaller dose there is no reaction except 
pallor, oough and anxious facial expression. 
Reese (22) states that such an attack, simulating 
petit mal, creates a fear complex with a seneation of 
impending death. Repeated failures to produce convulsion•, 
and thus amnesia, develop reactions which soon result 
in objective aversion, opposition and refusal to aooept 
this therapy. According to Oook and Walters (24) the 
symptoms of the psychosis may be more pronounced than 
before the injection. Friedman (19) reached the same 
conclusion after a number of patients, who were progress-
ing n1oely,suddenly had relapses after suboonvulsive or 
"petit mal" doses. 
Friedman (19) therefore uses the following teahnic: 
!he initial dose of metrazol is the same as mentioned 
above. If a convulsion does not take plaoe within one 
minute, another injection of one co. more than the 
original amount is g1 ven. If again a seizure does not °'" 
take place, the treatment is taken up the following 
morning beginning with one ca. more than the last dose. 
This prooedure is repeated until a convulsion occurs. He 
finds that even in aaees of the most resistive t:vpe, a 
oonYU.lsion will ocour on tbe third or fourth day 0£ the 
treatment at most. Ae high as £orty six oc. has been 
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given by him in a single period in increments of 16 
plus 16 plus 14 co. without deleteriou9 effects on the 
oardiova9cular system. 
Low et al do not hesitate to repeat the injeotion 
after about thirty minutes have elapsed. (17} 
Reese state9 that in order to avoid the objections 
and psychic irritations in metrazol failures he had adopt-
ed the recommendation of Georgi. That is, insulin in 
shook producing amounts is given, and after two hours 
of }l.Upoglyoemia the patient is given a convulsion with 
metrazol. The convulsions terminate the patients' hypo-
glycemia state and he is able to take the sugar water. 
The reaction to metrazol as described by uook and 
Walter {24), Friedman (18), Low (17}, Finkleman (14), 
and Himwioh (25), takes place in the following manner. 
Within two to :rive seconds after the intravenous admin-
istration of metrazol there is a blepharospasm and 
mouth twitching and the patient coughs. Five seoonds 
later, ten seconds after the injection, marked pallor 
of the face ooours. From eight to twenty seoonds after 
the injection a tonic convulsion begins in the face, 
shoulder~ and arms. This lagts from two to ten seconds. 
This 19 followed in about fifteen seconds, ten to thirty 
seoonds after the injeotion, by a clonio phase with the 
head retraated and the baok arched. The wrists and legs 
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assume various pogtures. The alonic phase lasts from five 
to thirty seconds and is followed by another tonic phase, 
aightean to forty seconds after the injection, which 
begins in the fingers and then spread 9 to involve the 
entire body. 'l'hese movements are rapid at first and then 
gradually become less frequent, cea'3ing in from twenty five 
to fifty five seconds. During the tonic phase the face is 
:flushed.. As the olonio phaed sets iu, oyanosie uevelopa 
and continues throughout the clonio spa.gm. Coincident with 
the cyanosis the flush turns to pallor which is usually 
followed by a period of apnoea lasting a few seconds. 
Within a. few more seoonds the patient resumeg breathing. 
At this time according to Himwioh et al (52) the amount 
of oxygen available for brain metabolism is reduced and 
this may be an important factor in explaining the benefit 
obtained from the convulsive seizure. The entire gpasm 
is over in about sixty or seventy seconds. The pupils 
are nearly always dilated throughout the reaction ana 
the eyes often show extreme lateral deviation. Brief 
after twitches may occur as late as a minute or two 
after the paroxysm. Occasionally micturat1on ooours. 
After the convulsion patients frequently fall asleep for 
a few minutes or in some oases for several hours. Others 
di splay great motor- regtless11a9e without any well defined 
28 
pattern. Usually patients remember only the injeotion and 
the feeling of anxiety and have amnesia for the rest of 
the seizure. (23) It is unwise for one patient to see 
another during the oonvulsion and treatment should be 
given individually. 
The treatment is continued until the patient shows 
a remission. As a general .rule. it has been found help-
ful to induce a minimum of about twenty five reactions 
of "grand mal" type before abandoning treatment in oases 
of ~ailure to respond. Patients who respond should be 
treated until the maximum improvement or remission oan 
be noted. ~'hen, it is believed. three or four addi tiona.l 
seizures should be induced to prevent the possibility 
of relapse. In the event a relapse ooours, therapy is 
reinstituted until improvement is again noted. 
Metrazol is not used to the exclusion of other rec-
ognized means of treatment. The various oooupational, 
reoreational and reeduoatione.l routines are instituted 
in coordination with metrazol therapy. Psyohotherapeut1o 
advances should not be foroed on the patient.; rather 
these advances should lag behind the progress of the 
patient. Friedman and Meduna {19) have the patient come 
to their offices for interviewg at the termination of 
every four or five seizures. A full or complete remiss• 
ion cannot be said to have occurred unless there is 
oomplete insight and until the patient has satisfactorily 
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worked out and assumed a aritical attitude toward 
his pathologic experiences. 
The ocourrence of three or four convulsions are 
not regarded as harmful. However if they tend to 
continue beyond this number or tend to merge, inter-
vention is neoeesary. 'lhe~e oonvulsions are easily 
controlled by the intravenous use of the standard 
barbiturates, hypodermic administration of morphine 
and atropine, reotal administration of ether or avert1n 
with amylene hydrate, or inhalation of ether, chloro-
form or ethyl chloride. (21) 
Oomplioations of this therapy may be classified 
as "meohanioal and inflainI:lB.tory". Meduna (13) lists 
no complications direotl7 referable to the drug a_ction 
in over a thousand oases. Du.ring the course of a con-
vulsive seizure mechanical injuries including dislocat-
ion or fracture of the jaw, arms or legs may occur 
unless prevented• It is inadvisable to prevent all move-
ment, but abduction of the limbs should be prevented. 
Injury to the tongue may be prevented by plaoing a soft 
rubber wedge between the teeth during the tonic phase 
when the mouth is open. (23) Low et al report that naseau 
and vomiting is not unooJm!lon after the first convulsion, 
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but that these disappear rapidly as treatment progresses. 
Friedman and Meduna (19) include "inflammatory complicat-
ions". These consist of pulmonary abscesses, activations 
of latent pulmonary tuberculosis, acute (myocardial) 
reactions. They have computed the incidence of complicat-
ions in a total of 2,937 American and European patients 
as 2. ~{,, both mechanical and infla?Ill!latory complications 
having equal values. Mortality in this series of oases 
was 0.29%. 
In schizophrenia, the results of this therapy are 
very encouraging. According to a number of statistical 
workers it has been found that the rate of spontaneous 
remission of schizophrenic patients varies between 
four and twelve per aent. (19) Finkleman (23) found 
that the rate of remission with metrazol therapy was 
almost inver~ely proportional to the duration of the 
psychosis. When the psychosis had lasted more than 
three years there was only a slight possibility of 
remission. American workers have classified oases of 
schizophrenia of lesg than six months duration as aobte, 
oases of less than twelve months duration as subaoute. 
and oaseg of two years duration or more as chronic. 
Meduna (13) Priedman (18) Kennedy (20) and Sorger (21} 
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report that more oor:iplete remissions are obtained in 
the a.oute oases of i:Johizophrenia. Meduna. (13) reports 
a remission rate of 82"fa in the acute oases. Low et al 
( 17) re go rt their percentage of recoveries as follows: 
aoute oases, 84.6%, 9uba.oute oases, 65.6~, and ohronic 
oases 28.6% Sarger and Hoffmans results compare very 
favorably, 76.3fo, 53.8%, and 26.5% respectively. Fried-
man and Meduna (19) in a review of the statistics of 
1,465 American oases treated in thirty seven hospitals 
report a remission of 60.96% in acute oases of sohiz-
oohren1a. a remi <:Jqion of 38 .8~"3% in aubaoute oases 
of schizophrenia, and a remission of 8.36% in the chronic 
oases of schizophrenia. huropaan statistics closely 
agree with these figures. 
Young and Young (14) state that while the therapeutic 
use of convulsions induced by r:ietrazol has been to data 
largely confined to the schizophrenia group, there is no 
reason to believe ths.t its effioaoy should be restricted 
to any special type of personality dysfunation. f.bey-. __ l<t~ve 
applied this form of therapy to the affective psychosis 
(depressionsi Twenty one suoh oases were treated and 
oomplete restoration was obtained in twelve of these 
oases. Six other oases were markedly improved 'by the 
treatment. Two others were improved and gradually rea-
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vered. One patient showed no improvement. These were 
seleoted oases. Bennett (16) reports twenty one patients 
with affective psychosis who all showed improvement 
within two weeks after oonvul'31Ve shook therapy was 
instituted. He 9tates that one relapsed to the manio 
9tate. His oases oonsisted of manio-depresei ve, 
reaoti ve and involutiona.l type'3 of psychoses. Low et 
al (17) have treated a group of sixteen patients with 
mania-depressive psyohosis. Of these five had the manic, 
nine the depressed and two the involutional typea of 
psyohoi:Jis. In tbis group were six patients whose present 
attaok had la'3ted more than two years. Five of this 
group of lix-reoovered. From these results Low et al 
infer that the rate of reoovery for manic-depressive 
psyohoeis does not depend on the duration of the attack. 
These writers report a case of anxiety neurosis of five 
years duration with remission by metrazol. In a case 
of hypochondria.sis of five years duration four metrazol 
oonvuleions produoed rem~ssion. They report a oase of 
"shell shook" neurosis of eight years duration with 
remission following :four metrazol oonvule1ons. 
The number of available reports relative to the mode 
of action of metrazol is limited. At the present time 
mo oonolus1on haa been reached as to ite exact mode of 
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aotion in removing or ameliorating the symptoms of 
mental di sea~e. Olinioal, laboratory and autopsy find-
ings have been of little assistanoe, Eleotro-enoephalo~ 
grama are of value especially with reference to negative 
findings. 
Oook and Walter (24) report that two different 
reaotions are recorded on the eleot~o-encephalogram, 
following the intravenous injection of metrasol. One 
type occurs when the 1nj•ot1ons fail to produce a 
convulsion, and the other is obtained when a convulsion 
ensues. 
When an injection fails to produce a convulsion, 
no change 14! 4leen in the electro-enoepbalogram at first• 
Then small waves; having a frequency of six per second, 
appear in all leads and involve all areas of the cortex. 
They increase gradually in size during the first minute 
and remain for a rru.mber of hours. Th• eleetro-enoephalo-
gram does not resemble in. any way that found in oases 
of petit mal for this condition ie ahe.rsoterized by a 
focal disoharge at a frequency of three per seoond. 
When an inj•otion is suooessful in produoing a 
convulsion the eleotro-enoephalogram starts in the same 
way after a latenoy of a few seoonde. Although the waves 
appear in all areas they grow more rapidly and have a 
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slightly lower frequency. Fifteen seconds following the 
injection there is an abrupt inoreasa in the size and a 
drop in the_trequanoy of the waves in the frontal region. 
This may ooour on either or on both sides. At this 
moment the tonic phase of the convulsion begins. The 
area involved by large slow waves increases in size and 
spreads over the greater part of the cortex. Ae the 
oonvuls1on passes into the olonio stage, the discharge 
becomes more staccato ~n rhythm and then ·suddenly ceases. 
about one or one and one half minutes following the , ' 
injection~ The eleotro-enoephalogram is now abnormally 
quiet, no waves of any sort being seen, and the patient 
is completely relaxed and flaooid. With the return of 
oonsoiousness the normal small random potentials reappear 
and thirty minut.es later neither the "patient Oil' eleotro-
enoephalogram show any trace of the storm which has 
agitated them." The striking feature of this type of re-
action is the sudden increase in potential and the drop 
in frequency in the area of the superior frontal gyrus. 
( 24) . 
As small doses of metrasollproduoe an abnormal dis-
charge in all areas, these authors state that it cannot 
be 9Upposed that metrazol has an entirely selective 
action on one part of the cortex. They state. "it may 
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be that when a certain concentration of oard1azol is 
reached, this frontal area becomes unstable and aats 
as detonator. for the re13t 9f the cortex which is alread7 
poisoned by the drug.·" They mentlQn that it should be 
remembered that the electrical threshold :f'or convulsive 
movements has been found to be lower in this area than 
1,n ·other parts of the brain. Another ·:possibility is 
that this area by reason of it~ anatomical connections 
is first to signal the onset of an abnormal condition 
in some euboortical center. (.24) 
Low et al ·c11) find the following values ten 
mi~tes after the oonVUlsiGJlS; (a) the )>lOOd pressure 
which wa~ usually nigher to begin with rose from about 
146 mm_. Hg.. to about 198 mr:1. Bg. , · (b) the p~lse and 
respiration were likewise increased, .Co) the mean value 
o:f' the pH fell from about 7.36 to 7.17, (d) oarbon . '·' 
dioxide volume percent fell from normals of about 10 
mg.% to about 8.75 mg.%, (f} fa~ting dextrose values 
rose from about thirty to sixty percent and remained 
in excess of preparoxyemal levels for at leagt three 
' 
houre. Sorger and Hofmann (l'I) also reported an increase 
in dextrose content of the blood immediately following 
the convulsion, a~taining its greatest height about 
thirt7 minutes later. This returned to normal within a 
few houre. Meduna (13) and Kennedy (20) find that 
during tbe three hour period folloWing the oonvuleion 
there ie a decrease in the urinary acidity, a. reduct-
ion in ammonia content and a considerable reduction 
in the urinary chloride. 
Only four fatal oases have been reported in the 
literature to date. In these deaths associated with 
metre.sol therapy preexisting pathol9gio ooniitions 
were present including aortic disease, hypernephroma 
and goiter, and pulmonary embolism and pelvic thrornbo-
phlebitis. Hayman and Brady report a case of a man of 
twenty four years of age,wbose physical and laboratory 
data was negative, who suddenly died after the sixth 
treatment following the injection of 5 oo. of,metrazol. 
Morbid anatomy revealed marked congestion of all of 
the organs and a preexistant endooarditis with no other 
distinct lesion. They state that the probable cause of 
death was "the toxio effect of a pharmaoologio agent on 
a pathologically impaired heart." (24,25) 
:B'riedman (18) believes it is possible to think 
theoretically of schizophrenia ag a result of general 
sluggishnegs of mody metabolism and that in schizophrenia 
there might be, again theoretioally, a phye1olog1oal 
barrier to certain thought processes which would tend 
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to beoome more impenetrab1e as the disease progres9ed. 
In hie opinion the benefit from metrazol therapy is 
brought about by a stimu1at1on or irritation of the 
whole oentral ne'rvous system to the extent that these 
so oalled barrier':3 ,,.e,re broken down, allowing proper 
thought proaessee to be carried on. The aotion of the 
alkalinization is that of increasing the irritative 
background so that tolerance to the oonvulsant drugs 
is lowered and the aotion of the latter ie more rapid. 
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Oamphor 
Oampho.r in the form of a twenty five peroent oily 
solution given intramuscularly is another type of the 
irritative therapy of the psychoses. The indications 
and contraindications for the use of camphor as a oon-
vulei ve urug are eseen~i&ll7 those of irritative drugs 
in general. These pha9es have been di9cussed with 
relation to the use of metrasol. 
A freshly· prepared sterile solution of camphor 11 
injected twice daily only a~er the urine has been 
alkaline for two days. ~he initial dose is placed at 
16 oo. {4.0 G) and the subsequent doses are increased 
at the rate of 4 oe. per day •. When convulsions occur 
at any given dose, the injection is omitted the follow-
ing day, and the next dose is the same as the oonvuls-
ant dose. If convulsions do not occur after four inject-
ions, three or four days are allowed to elapse before 
the injections are re911J'Ded. They are then resumed at an 
increase of 4 cc. to 6 cc. ~·he maximum dose of camphor 
1e set at 56 oo. {14 G). (18) Meduna determined that 
the convulsive dose of camphor varies not only in the 
different patients but algo in the same patient at diff-
erent times. 
Convulsions ooour from fifteen minutes to three 
hours after the injection, and as high as six individual 
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oonvulsions haTe been noted. The oonVllleions are 
manifested over a longer period of time than are those 
occurring with metrazol, and usually ooour without any 
warning. C18) 
Irregardless of whether convulsions occur Frtedman 
noted that there is a"deleri-form or twilight state 
somewhat similar to an. individual mildly under the 
1nfleunoe of alcohol or oanniba9." He states that the 
patients walk about as though dazed and that reactivity 
to vivid and painfUl hallucinations, obiefly of the 
somatic is frequently noted. This reactivity differs 
in many ways 'from the reactivity and the content of 
the hallucinations noted before the treatment wa.e c:Jtart-
•d. According to Friedman this difference was noticeably 
eign1g1oa.nt in- that the patient registered concern and 
anxiety .about the halluoination. Ocoasionally the 
. patient .would become assaultive and destro.oti ve. !i.'hese 
reactions t_o camphor may remain for a.s long as ten days 
following the last injection. Patients, upon reoovery, 
relate that there is only partial amneaia.(18) 
The immediate obnoxious effects of camphor are 
naseau, emesis, a mild form of ataxia and infrequent 
oomplainte malaise and pains in the extremities. Two 
oases of bilateral subcutaneous absoe'3ees in the gluteal 
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region resulting from camphor injections have been 
reported. 
41 
SHOOK Tl:IEBAPY 
Insulin Shook 
Insulin ehoak was 1ntrocluoed by Sakal at Professor 
Potzels' olinio in Vienna in October, 1933, as a new 
form of therapy in mental disease. Prior to thi e time 
insulin, in '3lllaller amounts, had been used in the treat-
ment of the psyohoses. Oowie, Pareone and Raphael tried 
a oombine.tion of from two to ten units of in9ulin with 
glucose in oa'3es of depression without resulting signs 
of olinioe.l improvement. They did note that the prolonged 
dextrose utilization curve was changed by insulin to a 
normal aurve. Targowla and Lamaohe in 1926 and Puoa in 
1927 suooessfully used daily do sea of up to forty fi va 
units of insulin aombined w1 th glucose to improve the 
appetite and nutrition of patients. They noted the dis-
appearanoe in the oourse of tre1c,,tmant of the motor sympt-
oms of a eubjaot with catatonic '3tupor. Appel, Fa.rr, and 
:Marshall in 1928 used immlin in the treatment of thirty 
three patients with psycshosea who pre'3ented intractable 
malnutrition. They noted s. definite improvement in the 
mental statue in twenty per oent of theae patients. Paul 
Schmidt in 1928 wa~ the first to deliberately use insulin 
for its therapeutic effeot on the psychoses as suoh. He 
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ad1n1nistered from sixty to eighty units of insulin a day 
and noted that stuporous patients grew aotive and that 
agitated patients grew oalm. All of these authors and 
numerous others used oarbohydrates in conjunction with 
insulin and strenuously avoided h7Poglyoemia shoak.(26,27) 
The applioation of insulin shook in the treatment of 
eahizophrenia developed purely empirically as an outgrowth 
of 8akel's original employment of insulin in the manage-
ment of the withdrawal s~ptomfJ in morphine addiote. In 
oonneation with this ~akel observed that the oooasionally 
unavoidable hypoglycemia states whioh d•veloped in these 
patients in spite of the faot that the administration of 
the insulin wag accompanied by the simultaneous administ-
ration of carbohydrates had a distinctly quieting effeot 
on motor excitement~. He than extended the application 
of this treatment to various forms of eahizophrenio dis-
orders and made the signifioa.nt dieoovery that the insulin 
shook :proved to be of benefit in the treatment of sohiz-
ophrenia. ( 26. 28, 29, 30} 
Since its itroduotion in Vienna in 1933 it hae been 
employed in publio mental hospita.19 in Switzerland 9 in 
the Netherlands, in Poland and in isolated German olinios, 
in the Moscow Psyahiatria Clinic and in the United Btatea. 
With regard to indioationst thie form of therapy has 
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been ·limited almost exolusively to soh1zophren1o disorders. 
Ree9e (22) states that all patients with schi1ophrenio 
psychoses should be submitted to insulin therapy before 
attempting other forms of therap7. Of these patients he 
states that patients with early paranoid and catatonic 
disease offer a more favorable prognosis with insulin where• 
a• stuporous catatonia and depres9ed hebephrenic subjeote 
respond better to metraaol. Frostig (31) also believe the 
treatment to be worth while in aasee of incipient parano14 
development. It is not unlikely that, in the future, this 
form of therapy will be extended to other formt of mental 
disea!3e. 
Knowledge of contraindications for the treatment is 
still incomplete. ~rostig (31) exoludes all psyohot1o 
patients with severe physical symptoms from treatment. 
Reese and Vander Veer state that coronary disease, severe 
pulmonary disorders and aevere cardiac disorders are 
absolute contraindications. Experience ha9 shown that the 
response to insulin treatment stands in inverse ratio to 
the duration of the illness. Reese and Vander Veer do not 
apply this treatment to patients over forty years of age. 
( 32) 
Regular insulin is used in this type of therapy. 
Reese and Vander Veer experimenting with protamine zinc 
in'1Ul1n report that it is a1mo'3t impossible to produce 
oomatose shook even with large doeee of this oompound and 
with blood sugar levels ae-low a'3 18 to 20 mg, Likewise 
the effect is inconstant. They therefore abandoned this 
method of procedure after a month and returned to the use 
of regular insulin. (33) 
The technique requires that the patient be given in· 
areasing doses of insulin until the so oalled shook dose 
is reached. A shook dose is defined as that a.mount of 
insulin whioh in any individual produoes deep coma with 
areflexia within four or five hours after one injection, 
(30) The term "oorna" should be associated with the absence 
of the corneal reflex or at lea~t with the presence of a 
Babinski. The duration and depth of the ooma vary with the 
dose of insulin and with the ~ensitivity of the patient; 
the reaction is dependent partly on the endocrine balanoe 
of the patient and partly on metabolic conditions and 
other unknown factore.(3l)Response to any one dose varies 
from individual to individual and in the same individual 
at different tines. The size of the shook dose also varies 
oonsiderably in different individuals and may be anything 
from 15 to 450 unite.(26,28,29,Q0,31,32) Reese states that 
hydration or dehydration, alkalinization or aaidiemus, 
administration of oxygen or atropine have not infleunced 
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materially oliniaal symptoms or phasia course of ineulin 
induoed hypoglyoemia.(22)The treatment has been diYided 
into four stages by Sakel. Phase I is the introduotory 
phase; phase II is the phase of severe shook; phase III 
1• the phase of res~; and phase IV is the terminal phase. 
(29, 31) The intensity and duration of eaah phase is 
strictly graduated with the requirements of the individual 
case. 
Phase I consists of graduated intramu.soular inject-
ions of regular insulin. Wortis (34) sugge~ts that the 
patient be prophylaotioally digitalized for eix to eight 
days during tbie phase. The sise of the initial dose of 
insulin used varies with different experimenters. !be 
aphorism, "eXperience is fallaoioua and judgment diffioult" 
is nowhere more apropos than in conneotion with the 
variability of the individual's responee to insulin. In 
8akel's original report the initial dose varie4 from between 
twelve to twenty unite. This initial dose was then in-
oreased by five to ten unite six days a week followed by 
the so called rest day when the treatment ie omitted. This 
was given on an empty stomaoh between geven and seven 
' thirty in the morning. The patient was then kept in bed 
and about four or five hours later was given from 150 to 
200 grams of sugar in tea, water or milk by mouth and 
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shortly a~erward hie regular mid day meal. During the 
rest of the day the patient was permitted to oarry on the 
usual hospital routine unless prev~nted from doing so by 
oertain special oonditions. In oase of marked exoi tement 
another injeotion of the same dose of insulin was administ-
ered at two o'clook in the afternoon and this was followed 
by the neutralizing oarbohydrate within two hours. (29) 
More reoently Sakel has advocated an initial dose of from 
between fifteen and fifty units of insulin, and a daily 
increase of from five to twenty units. Reese and Vander 
Veer, after the findings for the blood and urine have 
been oheoked for several days and the sugar toleranoe and 
reaotivity to insulin are established for the patient 
seleoted,submit their patients to an initial dose of 60 
units ~f insulin. The daily inorease ranges from ten to 
thirty units. (30, 32). Frostig (31) uses an initial dose 
of from ten to twenty units of insulin with a daily inoreaee 
of from five to twenty unite. He warn9 againet too rapid 
an inorease in the doses, since symptoms of oollapse or of 
protracted shook may ensue. Just how far thie first phase 
ha9 to be carried until the second phase is reaohed is 
eubjeot to great variation. Apart from the well know faot 
of individual differenoas in sensitivity to insulin, the 
differenoes in the $ymptoms which appear in the hy:po-
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glyoemio state seem to determine the degree of reaotivity 
of insulin antagonists (adrenalin, pituitrin) whiah affeots 
in turn the progress of the hypoglyoemio state. Thus in 
Oa9es with aonsiderable musoular irritability there ie 
probably a greater tendenay towards an adrenalin neutral4 
ization of the effeots of insulin. Aooording to Sakal, 
old oa9es of sohizophrenia seem to be more re9i~t1ve to 
the infleunoe of insulin than recent oases. (29) Frostig 
(31) reports that insulin shook may etart, in some oases, 
with as little as twenty unite of insulin. Katzenelbogen 
et al (35) report that shook producing doses in their 
series of oase9 varied from 25 to 200 unite of insulin. 
Wortis et al (36) report shook dosages varying from 40 to 
165 units of insulin. Reese and Vander Veer (33) state 
that they were able to obtain deep comatose hypoglyoemio 
shook with from 70 to 220 units of insulin. Gluoek (29) 
observed one patient who failed to show the slightest 
phyeioal or psyohio signs of hypoglycemia after repeated 
injeotions of a many as 240 units of insulin. Vander 
Veer and Reese (37) report that there i'3 no correlation 
between constitutional (weight, height eta.) or psyohio 
factors and the size of the shook produoing dose. 
The precise point of transition from phase I to 
phase II is to a large extent arbitratily determined. 
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Phase II is the so oalled shook phase, the most import-
ant stage in the treatment. In praotioe this stage is 
assumed to have been reaohed when the dosage of ineulin 
produaea a degree of ooma whioh no longer enables the 
patient to drink the 9Ugar eolution voluntarily and nasal 
tube feeding has to be resorted to, or irrespective of 
the degree of ooma and other manifestations of deep 
hypoglyoemio state the patient is threatened with a con-
vulsive sei3ure. (29,31) As this stage is approaohe4, 
the patients should be prophylaotioally tubed before 
eaoh treatment~ Patients may be permitted fluids during 
the shook, and throughout this phase laxatives and 
sedatives are prasoribed as needed. Special attention 
should be oonoentrated on preventing the baokflow of 
ealive. •. (26) It is in this phase of the treat:r.ient that 
one must be ready for emergenoy intervention, either 
through the intravenous administration of a 33 to 40~ 
gluoose solution (at times as mu?h a9 150 to 180 co. 
is necessary before the hypoglycemia is neutralized) or 
in addition also through the hypodermic administration 
of adrenalin and at times of oardiao and respiratory 
stimulants. The nasal administration of an a.o.-.uate 
amount of sugar cu9t ne7ertheless also be carried out. 
(26,35,35) 
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Onoe the shook dose has been determined for any patient, 
the amount ia usually adhered to for some time; ohanges 
are required from time to time by variations in the 
patients. activity, Moreover,~ during the oourse ot treat-
ment eensi ti vi ty to incmlin u'3Ually manifests i t'3elf, 
requiring frequent reduction in the shook dose. (2G,29, 
30,31,32,34,35,36,37) Ca~es have been reported where it 
was possible to reduoe the insulin from 160 to 30 units, 
deep shook being produced with both doses; and from 
80 to 25 units. (32) Treatment is oontinued for from 
five to six days a week until it is apparent that no 
further progrese oan be made. Frostig (31) reoocunends 
that small doses of insulin (from 20 to 30 units) be 
given even on rest days in some oases to oover the 
oarbohydrate requirements of the day. Aooording to Reese 
(22) the total period of hy:poglyoemia should not exoeed 
six hours. The lowest glyoemia is reaohed from one to 
two hours after the injeotion and this corresponds to 
the oritioal physiologic danger zone, i.e. when hypo-
glyoemio irritation phenomena ba'gtnito1:iapptmr•)r:.(22,35) 
It is during this ti~e that oomplioations may ooour 
whioh require immediate termination of the shook. These 
oomplioations will be discussed later. 
Termination of ooma may be effeote• in four differ-
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ant ways. In the ltghter degrees of ooma the patient oan 
swallow, and two glasses of sugar and water, tea or egg-
nog, oontaining ninety grame of suorose to the glass, are 
suffioient to terminate the ooma. As soon as full aonsaious-
nese returns a meal rich in carbohydrate should be given. 
The seoond method consists of the administration of the 
sugar solution through the nasal tube. This is the method 
routinely used to terminate ooma. In ~hese two methods 
termination of the aoma is usually attained from fifteen 
to forty five minutes following the administration of 
the sugar. If the patient is in deep coma, he may be 
brought to full aonscioueness in from one to five min-
utes by the intravenous injection of a fifty per oent 
solution of dextrose. Usually from 10 to 30 co. is suff ... 
ioient. This is the method of choice when quiok interrupt-
ion is necessary. It has the disadvantage of aausing 
gradual venous thrombosis when used daily, and its use 
should always be followed by a physiologioal solution of 
sodium chloride. A final method of terminating shock is 
the intramuscular injection of from l to 2 oo. of a l: 
1000, solution of epinephrine. 7his prooedure is reoommend-
ed especially for the termination of epileptiform shook. 
( 26' 32, 37} 
Phase III is merely a tranqition stage between 
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phases : II and IV. It is really limited to a designation 
of the usual and the oooasionally unavoidable rest periods 
in the treatment; that is the usual seventh day every 
week. After epileptic seizure the patient is usually 
allowed three days freedom of the treatment, ( 26) 
Phase IV refers only to the oases in which the pre-
oeeding treatment led to the desired result. That is, 
when the patient is recovered and when psychotic phen-
omena no longer ooaur in the course of· hypoglycemia. In 
this phase the amount of insulin administered is reduced 
by from 20 to 40 units a day, and the carbohydrates are 
administered no later than two hours after the insulin-
ization. (26,31) 
In a recent article Vander Veer and Reese state 
that if improvement is to ooour some indications are 
present within three or four weeks following the instit-
ution of the therapy. If from thirty to thirty five 
deep comas have not favorably modified the patient's 
conditions, the treatment is discontinued by them.(37) 
Young et al (14) oonaur in this. opinion. Frostig (31) 
considers the maximum number of severe shooks to be 
fifty. If after this number of shooks the patient does 
not show signs of improvement he is then dismissed ae 
"unimproved." He states that in oases in which no marked 
improvement has occurred but in whioh the prognosis seems 
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favorable, the maximum number of CJbooks may be extended.· 
Re~se oon9iders sixty days the minimum for in~ulin treat-
ment with almost ninty days for older diseage. (22) 
Sakel attempts to formulate more preoise rules for 
the administration of this treatment in the paranoid, 
oatatonio, and oatatonio excitement types of schizophrenia. 
He believe9 that the hypoglycemia suppre99a9 the moment-
arily most active part of the psyake and thus makes poss~ 
ible the amergenoe of the latent aspeots of the psyoke, 
whioh then supplants to a greater or less extent the 
aoute existing manifestatione,whiah have already been 
repreesed by the insulin. Acoording to him, before the 
stage of complete aoma is reached, the hypoglyoemia in-
hibits and delimits the existing· {pgyohotic) eta.ta and 
oonvarts it into the opposite. Thus a mania patient becomes 
depressed and a confused patient beoomes luoid. He states 
that he has been able to observe in many, if not in all, 
aaaes that a halluoinated or delusional patient would 
manife~t a brief period of oomplete luaidity juat before 
falling into deep ooma. The same patient, after the improve-
ment has progressed far enough to enable hiw to behave 
quite normally when not in the hypoglyoe~io state will, 
I 
during the shook, become aoutaly psychotic again for a 
brief period before sin~:ing into deep ooma. Sakal terms 
this the "activated psychosis". (26,30) This phenomena 
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has also been noted by other observers. (31,32,38) aakel 
further refers to the strong tendenoy towards the fixation 
of the condition whioh exists at the time of the interrupt· 
ion of the hy!_)oglyoemia. In the main this refers to oond-
i ti ons o.f p~asi vi t;y auO. aoti vi ty, a.nu oi axoi tement b.l1U 
oalm. Thus the interruption of the shook in the case of 
an excited catatonic during a state of calm and passivity 
would tend to e~tablish a similar condition also for the 
non hypoglycemic phases. Conversely, in the case of a 
stuporous patient the interruption of the shook during 
a stage of activity and excitement would tend to continue 
to activate the patient outside of his hypoglycemia state. 
He accordingly stresses the importance of determing the 
most advantageous moment for interrupting the shook. (26,30) 
In the Oa9e of patients who are predominately stupor-
ous, the hypoglycemia is interrupted at the fir'3t indioat-
ions of aotiv~tion either in the form of some release 
phenomenon or an excitement in order to a'3tablish a oond-
i ti on whi ob is, a'3 much a'3 possible, in contrast to the 
existing stupor. 
For those oa~es whioh are predominately paranoid in 
oharacter the hypoglyoemio state is permitted to reach a 
deep degree of coma and the shook is never interrupted 
during the manifestation of an activated psychosis. The 
aim here is essentially a9 complete as possible a suppress-
ion of the existing psychotic state, and the favoring of 
as complete an amnesia as possible. 
With regard to the oatatonio exeitement~ Sakal ~tatee 
that from the very beginning he and his assooiates were 
impressed with the fact that this type of patient did not 
re1pond as favorably as the othe~s to the hypoglycemic 
state. He proceeds in treating this type of patient as in 
the others with from fifteen to twenty unite, but he 
administers this from two to three tir::es daily because of 
the need of quieting the excitement. The dose is inoreaeed 
daily by from five to ten uni ts. iihen the patient quiets 
down, the hypoglycemia is induced only once daily and, 
during the early stages in the treatment, 19 terminated 
through the mere administration of food, later through 
the usual administration of sugar. After the shook dose 
is attained the most favorable point for interruption 
seems to be the moment of maximum eomnolenoe and just 
before the patient sinks into a deep oonm.. (26) 
In the oourse of phase I the olinioal hypoglycemic 
manifestations begin to ooaur. usually with increasing 
intensity. These symptoms of hypoglycemia are dependent 
more upon the rapidity of the change in the oonoentration 
of the blood sugar rather than the actual amount of sugar 
in the blood. Thus a patient whose blood sugar has been 
lowered gradually may have no symptoms whatsoever. Tbe 
hypoglyoemio raaotions in sahizophrenia are es~entially 
similar to those observed in patients who are mentally 
normal. Subjectively the patients experience a oertain 
sedative feeling, a pleasant feeling of warmth throughout 
the body, and slight paresthesiag of the finger tips, 
palms of the hands and around the mouth. Oooasionally 
they oomplain of a slight anxious, oppressed. feeling 
around the heart, pounding of the heart and double vision. 
The only raaotion during the first few days of therapy 
ooours about one hour after the injection and consists of 
sensations of hunger and light perspiration. On the eeoond, 
third, and fourth days, the patient often does not reaat 
as muoh as be did on the first day. After this the extent 
of the reaction generally parallels the amount of insulin 
given. As the dose is increased. greater degrees of bypo-
glyoemia are produaed, and the patient falls into progress-
ively deeper phages of in!!Ulin shook. The light perep1rat-
1on proceeds to profuse i1aphoresie and there is ueuall7 
inorea~ed salivation of a peouliarly visoid type. During 
the fourth or fifth day of treatment somnolence, slurred 
speech, ataxia, confusion, diploplia and often euphoria 
are superimposed upon the previous reaction. Following 
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this some degree of purposeless psyahomotor aotivity is 
added to the reaction. This occasionally reaches a stage 
of wild excitement. This stage of excitement is comparable 
to the state of confusion in mentally normal hypoglyoemio 
patients._Some patients do not experience this stage of 
exoitement but quietly pass into the stage of coma. Tremor 
may ooour early in this stage. Later on motor excitement 
in the form of olonio twitohings of the nmsoulature of 
the extremities, shoulder girdle, and face appear. As th.e 
shook dose is approached the sensation of hunger disappears 
its appearanoe being forestalled perhaps by the onset of 
the ooma. (26,31,32,38,39,40) The beginning of shook is 
characterized by the appearance of motor disturbances, 
suoh as clonic spasms and epileptiform oonvttlsions, and 
by lose of contact with the outside world. 
!hree types of shook, wet, dry, and oonvulsive, have 
been reported• The wet shook is the most desirable and the 
oommonest type of reaotion. 
The sequence of events of wet shook is comparatively 
oonstant and typical and recapitulates breifly the response 
of the patient during the first few days of treatment. 
The patient passes through the stages of somnolence, sleep 
(patient oan be aroused), incipient oorne. (patient cannot 
be aroused when called), eopor (deep sleep from whioh the 
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patient oan be aroused by oertain strong ~timuli), and 
ooma (patient oan no longer be aroused by any stimulus). 
Likewi9e, progressive motor phenomena appear as suooess~ 
ive levels of hypoglycemia are attained. These will be 
disoussed in the order of their appearance. MOtor rest-
lessness and tremor, as previously mentioned, may oeour 
in the early stages of treatment. This is followed by a 
mild degree of hypotonia and clonio twitohings. incoord-
ination, anomalies of tonic reflexes, ohoreio and myo-
olonio twitchings then appear and are followei by the 
disappearance of normal reflexes and the appearance 
of pathological reflexes. ( Babinski, Oppenheim, eto.) 
There is then a disappearance of all 9pontaneous movement 
and of all defense rea.otions • .!following this there is a 
diminution of muscle tone and a disappearance of tendon 
reactions. Finally the pathological reflexes disappear 
with areflexia and final general hypotonia. The pupils 
usually remain normal or slightly dilated. Marked contract-
ion occurs only oocasionally. Se.kel notes very marked 
tonic attitudes and movements reminiscent of the deoerebr-
ate animal. (26,31,32,35,38) Various vegetative and vaso-
motor symptoms occur as a result of the hypoglyoemia. 
The blood pressure usually varies within normal limits. 
Bradyoardia first occurs, and this is then followed by 
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tachycardia during the stage of excitement. With the onset 
of coma the pulse rate is first decreased and it then 
returns to normal or above normal. The respiratory rate 
fluctuates within narrow limits. Deviation•: below the 
normal is not significant. Irregu.lar. stertorous respirat-
ion during the oomatose state is quite frequent. The 
temparature usually decreases. A drop from 98.6 to 93 or 
94 19 not infrequent. Perspiration and increased salivat-
ion is present in eighty eight per cent of the oases. 
Vasomotor disturbanoes including pallor, flushing and 
oyanosis may be manifested. (31,32.35) On the whole there 
ie a tendency for the mental phenomena to follow a oertain 
pattern. The subjective reaction occurring in phase I has 
already been discussed. Kepler and Moersoh (38) report 
that some of their more lucid patients, in refering to 
their subjective impressions during insulin shook, state 
that they seem to be overtaken by a sense of intoxioation 
which causes them to pass gradually into oblivion and 
whioh leaves them without any memory of the period of 
ooma. Patients who have hallucinations almost never report 
them as occurring in shook, probably because of the partial 
amnesia which exists for the hypoglycemic period. Refer-
enoe has already been made to the luaid interval. This 
first appears in immediate realtion to hypoglyoe.mia, 
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either in the preoomatose phase or immediately following 
the termination of the coma. Likewise it is in this phase 
that manifestations in the nature of aoting out of the 
tendencies which seem to have a distinct bearing on the 
oontent of the :patients psychosis ire )olJss·rved. These 
ooour relatively late in the course of treatment. (26,30, 
31,32,38) In recovery from ooma the subject exhibits the 
same symptoms as when entering the ooma, but in the reverse 
order. '.l'he higher functions, especially speech, are the 
last to reassert themselves. The patient may exhibit motor 
aphasia for from fifteen to twenty minutes after he is 
otherwise fully conscious. (32) All of the previously 
mentioned symptoms may ooour separately or in groups, and 
ooinoidentally or in succession. (31) In the ideal deep 
wet shook the subject is quiet and ·relaxed, sweats profuse-
ly in large drops and often droolg saliva by the ounce. 
The pulse is full and generally 91ow. The early weeks of 
insulin shock therapy are U9Ually stormy with diversified 
symptomatology. As the treatment oontinue9 and the sympt-
oms vanish, a period of aomparative quiet ensues, when the 
patients daily behavior shows only minor abnormalities 
and the shook is relatively calm throughout. 
Oooasionally the patient falls into coma with little 
or no sweating. When this reaction occurs it 1 s termed 
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dry shock. This is usually associated with varying degrees 
of motor activity from single myoolonio twitohinge to 
generalized myoolonio seizures with little or no cyanosis. 
The convulsive reaotions will be considered later. In an 
attempt to convert this dry shook into a wet shock, Heese 
and Vander Veer (32) administered pilooarpine hydrochloride. 
They administered from one tenth to one fifth grain of 
pilooarpine hydrochloride from one to two hours after 
the administration of insulin to a patient who constantly 
manifested dry shook with epileptic seizure~. This prod-
uced profuse diaphoresis and also prolonged the pre-
oonvulsi ve period of coma for about an· hour, but a con-
vulsion always occurred if the shook was allowed to oon-
ti nue. ( 31, 32) 
The last type of shook to be mentioned is the oon-
vulsi ve or epileptiform seizure. "J.·here is little uniformity 
of opinion with regard to the incidence of this type of 
reaction. no ssman and Uline ( 41) report that seventy five 
per cent of their cages have had one or more convulsive 
seizures. wortie et al (36) report that less than one 
third of their patients have had epiletpio seizures. This 
reaction may be oI variable appearance in some patients 
and of constant oeourrenoe in others. In some patients 1 t 
is impossible to find a dose of insulin that will produce 
ooma without convulsions. 1·wo types of epileptic seizure 
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may be described. The early epileptic seizure appears in 
dry shock, that is, before the end of the third hour after 
the injection of insulin. !h19 reaction is characterized 
by pallor, tachycardia, ory, oonjuga.te deviation of the 
head and eyes, tonic spasms followed by tonio-clonic 
spasms of epileptic type, cyanosis, and Babinski. These 
symptoms appear progressively, in the order named. The 
patients manifesting these reactions do not usually pass 
into deep coma, and these symptoms usually occur in light 
ooma before the onset of deep coma. However, there is 
usually unconsciousness during and for a short time follow-
ing an epileptic convulsion. ~his is followed by a cloud-
ing of the consciousness for a short time before the full 
recovery of consoiousness. The late epileptic seizure 
appears in wet shook, that is, three hours or more after 
the injection of insulin. These seizures have manifestat-
ions similar to those of the early type, but there is a 
preponderance of tonic features in late epileptic seizure. 
Lbe late epileptic seizure bas a tendency to repeat it-
self and may result in status epilepticus. (31,36,41) 
These convulsive qeizures are regarded as a dangerous 
complication of therapy by 9ome authors. Rossman and Oline 
(41) state that is has been their experience that this 
type of reaction is followed by definite improvement in 
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the condition of the patient. Gillies (43) reports a case 
of schizophrenia of one and one half years duration who, 
in the second week of insulin therapy, developed status 
epileptious which was relieved by energetic therapy. Thie 
series of seizures produced almost complete cure. He 
states that six months later she was still mentally normal. 
Reese and Vander Veer (32) state that these reactions, 
if mild, should be allowed to continue for a while, as 
they may terminate spontaneou'3ly. '..L'hey state that severe 
epileptiform seizures are rare, and demand immediate 
intervention and termination of the shook. They state 
that the appearance of convulsive reations is by no means 
a bad prognostic sign. This type of reaati,on will be 
discussed with reference to complications of insulin treat-
ment. Drabkin and Ravidin (44) suggest that the degree 
of hydration has a profound in:O.eunoe on the incidence 
of oonvulsion«J in insulin hypoglycemia. 'fhey state that 
the sequeµce of events leading to convulsions in insulin 
shook is as follows: (&) severe hypoglycemia; (b) e.n-
hydremia; (o~ rise of spinal fluid pressure to a critical 
level and, (d) convulsion. 
For convenience of description, I have classified 
the complioations of insulin therapy in three groups. 
In the first group are includei those complications 
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whioh are not necessarily confined to the period of hypo-
glycemia and which do not necessitate the termination of 
the shook. Complications that require early termination 
of the shook by feeding with the stomach tube comprise 
the second group. The last group consists of those oomp-
lioations in whiob immediate intervention is of vital 
importance. In this last group tennination is accomplished 
by the intravenous administration of dextrose, by the 
intramuscular injection of epinephrine, by veneseotion, 
and by spinal tap (15 co.) according to the severity of 
the complication. 
Vomiting may occur at any time during the hypoglycemia, 
and may occur following recovery from the shock. 1'bis 
complication may become serious if persistent, as it 
prevents the oral administration of carbohydrates, and 
results in a loss of carbohydrates. ~he application of a 
hot water bottle on the abdomen, the administration of 
the usual ·carbohydrates in fractions, and the reduction 
of the insulin dose are usually efficacious in the control 
of this oomplioation. Repeatet elevation in the afternoon 
temperature is usually indicative of an overdoee of insulin. 
As ~reviously mentioned, salivation is one of the most 
frequent phenomena of insulin shook. Partial asphyxia may 
ooour as the result of the accumulation of saliva in the 
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pharynx. Turning the patient on the side or stomach, to 
allow free drainage, is often enough to oombat this oond-
i tion; however, ocasionally shook must be terminated. 
After-shock, that is the occurrence of a second shook 
oocurring at a variable interval following the firet 
shock, may result from the insufficient administration 
of carbohydrates or from the loss of carbohydrates 
through vomiting. 1'hi s may be mistaken for normal sleep 
with the result that a dangerous hypoglycemia is produced. 
(31,32,34) 
The hunger-thirst excitement which occurs early in 
the treatment is an indication for the early termination 
of hypoglycemia in the opinion of many authors. In some 
cases the administration of saccharin, diluted to a con-
concentration of four grains to the quart, may quiet 
the patient enough for oor.ia to appear. ~·aohycardia, fluct-
uations of the pulse rate between 90 and 180, irregular 
soft pulse, and prolonged inspiratory dyspnoea accompanied 
by moderate oyanosis are also indications for the early 
termination of shock. '.I.'he shocl: should. b~ terminated by 
feeding through the tube if sustained extensor spasms 
appear after the final hypotonio phase of the shook. (31,32) 
Respiratory manifestations giving indication for the 
immediate termination of the shook include severe dyspnoea 
or apnoea, laryngospa':3ID with associated signs of apnoea, 
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and Uheyne-Stokes or bronohospagtio breathing. Cyanosis 
of the mucous membranes with a rapid, soft and thready 
pul9e and vascular collapse as .manifested by an irregular · 
pulse and by bradyaardia of under thirty five per minute 
likewise are indications for imr1ediate termination of the 
shock. There is great diversity of opinion as to the 
implications a.nd signifioanoe of epileptiform seizures. 
Early articles reported their ocourrenoe to be o:f poor 
porgnostio import, and they were classified as complicat-
ions. The more recent trend is to include these seizures 
in the therapeutic.regime, with only their late appear-
ance ( fourth to fifthJhour ) and the ooourrenoe of status 
epileptious )eing regarded as oomplioations deserving of 
immediate termination of the shook. Likewise, protracted 
shook was previously considered as an indication for the 
imL~ediate termination of the shook. As will be seen in 
the following section, this condition is being utilized 
in the treatment of the more chronic cases. (31,32,35,36, 
41,42,43) 
In reoording the results of insulin shook therapy it 
is suggested by Muller that the patients should be classif-
ied as to the duration of th~ir psychosis as follows: group 
I including illness of a duration of one half year; group 
II including illness of a duration of one year; group III 
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including illness of up to one and one-half years, an4 
group IV inoluding illness of over one and one-half years. 
Frostig suggests that the following classification of the 
&•gree of recovery be adopted: (a) complete recovery; (b) 
incomplete recovery: (c) partial recovery, and (d) no 
improvement. He reoornrnends that the following four criteria 
for complete recovery be adopted: (a) complete disappear-
ance of schizophrenia symptoms; (b) restoration of adequate 
emotional response; (o) oritical insight into the past 
illness, and (d) full capacity for return to former work. 
The patient is said to have recovered incompletely when 
any one of the preceding requirements is lacking.The term 
partial recovery is applied in oases in which certain of 
the symptoms have disappeared or in which the patient shows 
partial improvement as manifeatated by pacification, social 
behavior and capacity for work. (31) No uniform method of 
recording the duration of the psychosis and no method of 
recording the degree of recovery has been adopted as yet. 
This makes an accurate evaluation of the results of this 
therapy impossible. Therefore, only the original statistics 
publi9hed by Dussick and Sakel, which have in the main been 
reliably substantiated, will be included. One hundred four 
oases comprise this group of which fifty eight were recent 
(duration under one-half year) and forty six were older 
cases. 
6'/ 
In the group of fifty eight reoent oases, a good reoovery 
was made in eighty eight per oent enabling those patients 
to resume former oooupations in the community, while in 
seventy per cent a complete recovery was made. In the 
group of forty six older cases (duration of illness of 
more than one-half year) , a good social reoovery was made 
in 47.8 per cent, whereas a complete remission was obtain-
ed in only 19.6 per cent of the oases. Of the good remiss-
ions, fifteen patients have been well for about a year, 
and thirty four patients have been well for more than one-
half year. Of the group of recent cases there were nine 
relapses. Five of these patients were again placed on 
treatment, of whom three had a good recovery. (28,29) 
The mortailty in Europe has been placed at 1.6 per oent. 
(32} The effioaoy of this method of therapy is perceived 
when the above stati9tics are comps.red to the rate of 
spontaneous remission which is ten per cent. (45) 
The clinical findings of the hypoglycemia state have 
been previously disoussed. Attempts have been made to 
correlate the laboratory findings and the olinioal manifest-
ations. I shall not attempt to discuss the complete lab-
oratory correlations. Only those of import from: a therapeut-
ic standpoint will be mentioned. We have seen that there is 
no constant relation between the dose of insulin and the 
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intensity of the reaotion. Likewis~ there is no relation 
between the intensity of the reaction and the degree of 
hypoglycemia. To be eure.a drop of the blood sugar to below 
60 mgm. % is an essential preoondition for a clinioal 
reaotion. However, one repeatedly sees oases in whom a 
drop of the blood sugar to 30 mgm. % gives rise to no 
olinioal manifestations. In suoh oases a reaction may occur 
following the administration of a larger dose of insulin. 
!his inoreaCJe in dosage does not lower the blood sugar 
level however. The deepest stage of insulin shook does 
not necessarily oorrespond with the lowest point of -blood 
sugar content; on the contrary the blood sugar begins to 
rise at this particular point in most oases. Thus the blood 
sugar picture furnishes no indications as to the kind of 
olinioel manifestations one might expect. Most likely it .,. 
seems to be the case that a large part of the hypoglycemia 
symptoms are not due to hypoglycemia as such but are due 
to the reaction to the hypoglyoemiat that is, to the comp-
ensatory secretion of adrenalin. According to Kugelman, 
I 
the pounding of the heart. tremor, etc. are adrenalin 
symptoms, whereas the weakness, sweating, etc. are the 
direct result of the hypoglycemia. (35,39,46) 
As study o:f the blood sugar during ooma induced by 
insu.lin in schizophrenia has shown that the hypoglycemia 
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is never as low as the depth of the ooma might let it be 
expeoted, Fisher (46) investigated the role of the sugar 
level of the oerebrospinal fluid. His findings indioate 
that the individual :ragting values vary on a wide range. 
They are always higher than the blood levels and there is 
no evidence of a steady decline of them during subsequent 
comas. After the first hour the levels of the cerebro-
spinal fluid are muoh lower, and drop further~ as fast 
as those in the blood. In the course of the second and 
third hour they drop faster than the blood levels, and 
in the first half of the third hour the declining curve 
approaches and often ffalls on or crosses that of the blood 
levels. In the second half of the third hour, while the 
blood sugar.levels are on the increase and the coma i9 
deepest, the levels in the oerebrospinal fluid oontinue 
to drop and the curves diverge definitely. At the end of 
the ooma they begin to rise, but with a great individual 
range of variation, and always remai~lng lower than the 
blood levels. After the administration of sugar, the 
sugar levels in the oerebrospinal fluid re~uperate very 
slowly although some of the patients _are coming out of 
coma. A relation between the awakening and the sugar level 
of the oerebrospinal fluid is therefore oompletely out 
' . 
of the question. In certain oases the level remains low 
although the patient is wide awake and the blood shows 
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hyperglycemia. A hyperglyoorrhaohia has not been report-
ed. Dameshek and Myerson (47) demonstrated that following 
the administration of insulin the oxygen uptake by the 
brain was inversely proportional to the degree of the re-
aotion. They report an inoreaee of the spinal fluid pressure. 
Likewise they report that the administration of epinephrine 
regularly diminished the symptoms of the insulin reaotion. 
Hoagland et al (48) report the findings of the eleotro-
gram during insulin hyploglyoemia. ~hey have used the delta 
index as the criteria of reactivity. Thay find that the 
reoord is more "broken up" the deeper the ooma, and that 
this breaking up may occur as long as one hour previous 
to evidences clinically observable. lt was observed by 
them that the delta index in schizophrenic patients was 
much higher than it was in normal individuals. They report 
that the "post-sugar delta index" is le~s than the "pre-
insulin delta index". 
liumerous theories have been advanced to explain the 
mechanism of the neurologio symptom!'3. 111isher(46) etates 
that the ooma is due to the laok or sugar in the tissues, 
espeoially in the ga.nglial cells, and that this lack is 
not ~he cause but the effeot or a more profound disturb-
anoe or dysfunction in the nutrition of the oells • .l:ie 
espouse9 the opinion of Georgi to the e::rfeot that sugar 
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streams from the oerebrospinal fluid and there~ore also 
from the ganglial oells of the oortioal region, into the 
impoverished blood. This transfer oreates a "potential" 
which may, under certain oiroumstanoes, cause an epil&pti-
form attack. Olmsted and Taylor (49) find that the blood 
becomes more concentrated when the blood sugar reaches 
1 ts lowest level. '1'hey conolude that insulin convulsions 
are caused by increased cerebrospinal fluid pressure. 
resulting from anhydrernia. The epinephrine theory, based 
upon the similarity of the reaction to epinephrine and to 
insulin is rendered less logical by the recent demonstrat-
ion that the injeotion o:f epinephrine reduces rather than 
augments the symptoms o:f reaction. The anoxemia theory is 
based upon the diminution of the arteriovenous difference 
of oxygen content during hypoglycemia. (47) (38) 
Sakel (30) assumes a progressive development in the 
cell of pathways whioh are speoific to certain stimuli. 
He assumes a hairarohy of pathways. He believes that the 
older pathways are more resistive to insult. The more 
recently •stabl~shed pathways are more active and more 
sensitive to injury. Thus these recent pathways are the 
first to be affected by any insult to the organism. He 
believes that the changes occurring during hypoglycemia 
can be explained by the assumption that the hypoglycemia 
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bloaades the pathways which happen to be··most active at 
a given time, so that the reactions to the same stimuli, 
must come through pathways which had previously been in-
active • .lie assumes that by l~eeping the pathologically 
conditioned cell pathways in abeyance the originally 
normally conditioned pathways have a chance to reestablish 
themselves. Qualitative injury to the nerve cell causes 
injury to the youngest pathways first. The older pathways 
become involved as the injury becomes more severe. Thus 
during insulin shook the recently e9tablished pathological 
pathways are eliminated and only the older well established 
pre-psychotic pathways survive ana become re-animated. 
Up to the present, there has been no unanimity of 
opinion regarding the existence of pathologic changes in 
the central nervous system resulting from hypoglycemia. 
Terplan reported extensive zones of degeneration in the 
cortex of the brain. Subarachnoid hemorrhage and hemorr-
hage into the brain have been di9cussed by Freed and 
Wofford. (50.51) Kepler and Moersah have noted areas of 
solarotio nerve cells, zones of hyperohromatio changes 
in the cells and changes in the oligodendroglia and 
mieroglia following animal experimentation. These changes 
in the cells were noted to be most frequent in the third 
fifth layers of the cortex. (58) 
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Protracted Shook 
Mention of the protracted insulin shook has been 
intentionally omitted in the previous section. Tb.is had 
been previously considered a complication of in!JUlin shook 
therapy. At the pre"3ent time it is being employed by some 
psychiatrists a9 a therapeutic procedure. 
Kraulis (50) published an account of this method in 
May 1937. He was led to this method by the observation 
that certain oases who shortly after the beginning of 
the treatment, having undergone an unanticipated and an 
unwished for protracted shook (comatose state in spite 
of glucose administration and hyperglycemia), afterwards 
quickly imp oved and became continuously able to work. 
He has obse ved a total of 170 protracted insulin shooks 
in o patients. and he admits that such states 
of protract d shook are dangerous as it is impossible to 
infleunce t e course of the shook. Kore recent reports 
indicate th t it is possible to control the course of 
the the intravenous administration of crystall-
ine Bi. ( 51,52) 
suggests that this method be used only on the 
otherwise h peless oases of ohronio sohizophrenia. He 
seleoted o y those chronic oases who were completely 
sound physically, with particular reference to ~he heart 
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and lungs. Further oontra-indioations will be aonsidered 
in a disaussion of teohnic. 
The method consists essentially of prolonging the 
coma beyond the third hypoglycemia hour by the administrat• 
ion of small amounts of sugar by tube or by the admini st-
rati on of crystalline vitamin B1 • Thus a patient may 
be held in a comatose state for twelve or mor• hours in 
contrast to the one and one-half to two hours by the 
original method. According to Kraulis, less than twelve 
hour shooks have little or no_.;therape~1rict value .. :This 
treatment is given once weekly by him. 
Kraulie 91lg~ests that, following a clinical exam-
ination of the patient, a funotional test be made. Thie 
first protracted insulin shook is so conducted that the 
patient bas only a superficial or slight coma. In suoh 
a condition the corneal reflex in both eyes must remain 
active, • the patient may show only transitory respirat-
ory respiratory disturbances and the blood sugar must 
not sink lower after the sixth hypoglycemia hour, follow-
ing the usual O.osa of insulin. '..Lhe se oondi tions a.re 
attained through administration of sugar through the 
nasal tube which must remain continuously in place. Five 
grams of sugar is given immediately as soon as the patient 
no longer reaots to the introduction of the nasal tube. 
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Upon evidenoe that the patient is falling into a deeper 
degree of ooma, five to ten grams of sugar dissolved in 
a little water is to be given repeatedly. The depth of 
the ooma in suoh a procedure is so superficial that the 
patient often shows a tendenoy to awakening, and makes 
defensive movements when the muoous membranes are touched 
with cotton. Such superficial shooks have no therapeutic 
value, but they serve as a test of the function of the 
heart and respiration. These test protracted shocks are 
without danger for the patient and are easily terminated· 
by the admini strati on of sugar through the tube or by 
the intravenous administration of a small amount of 
glucose. If in the course of this shook a pulse rate of 
over 140 ooours, the pulse beoomes irregular or there 
is a dropping of individual beats. and there is unequal 
filling, the protracted shook should not be undertaken. 
A variable pulse rate within 60 to 140 beats to the 
minute, whereby the pulse is full and is regular, is 
no contra-indication for the protracted shook. Even so, 
the respiration must remain deep, regular, and equal. 
With respiratory disturbances which are not relieved b:y 
small sugar doses, and also apnoea or Cheyne-Stokes' 
breathing, treatment with protracted shook must be 
avoided. A test protracted shook of from seven to nine 
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hours suffioe9 in order to adequately evaluate the veg-
etative function, stability, and enduranoe of the patient. 
If the patient awakens before this time, the test shook 
must be repeated. (60) 
If the patient is to be plaoed on this type of treat-
ment, insulin in increasing doses is given as described 
in the section on insulin shock. After the shook dose 
is attained it is maintained and is never reduced. It 
has been found that increase in dose after a certain 
dose is reached results in no further reaction. On the 
day before treatment is commenced the patient reoeives 
his usual shook dose, and receives his la9t meal at four 
o'clock in the afternoon. The following day he receives 
the same dose of insulin or two or three units more at 
three o'clock in· the morning. This dosage must be chosen 
so that the patient develops his first somatic reaction, 
tremor or olonio movements, after the second hypoglycemic 
hour. If these symptor:.1s appear earlier, the dose ohosen 
is too high, and then one may not carry out the protract-
ed shook. Severe complications have resulted in suoh 
cases of too high dosage. (60,51) 
Kraulis recommends that five grams of sugar be 
given when the patient no longer reacts to the tube. 
Blood sugar determinations are made every hour through-
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out the treatment, but one should not be guided in a 
meohaniaal way by the sugar level. With the same depth of 
ooma, the sugar level may be twenty or 9irty milligrams 
per oent. Kraulis states that he has often seen threat-
ening situations with 50 mgm. % and conversely, easier 
awakening with 18 mgm. %. A continued sinking of the 
blood sugar level, in spite of repeated sugar administrat-
ion, is a dangerous sign. In suoh a oase the shoo~ shoul4 
be ended. The infleunoe of the oral sugar administration 
is usually seen in the blood sugar level after a lapse 
of from five to fifteen minutes. If ,one hour after the 
last dose of sugar, the blood sugar level shows a rise 
of from fifteen to twenty milligrams per oent 'higher than 
the estimation one hour previously, then one should be 
oareful about giving further sugar, because the patient 
may awaken with an additional dose of five grams of sugar. 
The ideal level of ooma is reaohed when the patient does 
not react to the to:1ahing of the :rnuaoue membrane of the 
mouth and nose. The corneal reflex in both eyes need· not 
be completely lost. Kraulis states that it is more advia• 
able to give small doses of sugar frequently rather than 
large doses at longer intervals. Two hundred grams of 
sugar is used to terminate the shock. ( 50) 
Rossman and Cline 151) reoommend that the duration 
and intensity of the shook be controlled by the intra-
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venous administration of orystalline vitamin B1 • They 
suggest that one milligram o:f vitamin B1 ( 250 internation-
al units) together with intravenous gluoose be given as 
soon as the reaction is established. This may be repeated, 
if necessary, after a few hours. 
Spontaneous awakening may be considered as a comp-
lication. This frequently oocurs when the patient has 
become accustomed to the dose of insulin. In suoh a case 
the dose should be increased by as mu.oh as twenty units. 
:!.:espiratory digturbanoes are the mogt :frequent oomplieat-
ion, and if severe, give indication for termination of 
the shook. Cardiac oomplioations, epileptic attacks, 
oonjugate deviation, olonio convulsions of the whole body, 
and other severe organic brain symptoms are of more serious 
import and give indications for immediate termination • 
The results obtained with this type of therapy are 
encouraging •. Rossman and Jline report a series of fifty-
two male patients, in whom the average duration of the 
peyohosis was 4.1 years, that received this method of 
therapy. They report that 11.5% reoovered, 28.13% were 
muoh improved, 42.~ were improved and 17.4% were unimprov- • 
ed. ( 51,52) 
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COKBIDJ> THEBAPY 
A combination of insulin and metrazol therapy has 
been found advantageous in the treatment of some cases. 
Reese (22) notes that in stuporous, depressed, or catat-
onic patients a drastic metabolic shake up with metrasol 
appears necessary to effect a response more favorable to 
insulin shook therapy. He recommends that when one method 
fails, the other should be tried. Young and Young (14) 
oite five groups of patients in whom this combined therapy 
has been applied. The first group consisted of patients 
who, after approximately three weeks on insulin, failed 
to show progress and were then given a series of metraaol 
treatments. In the second group of schizophrenic patients 
metrazol was given after their failure to attain coma on 
a dose of 200 units of insulin or over. They used metrazol 
in suoh oases as a less dangerous medicament. A third 
group of patients were given small doses of insulin in 
addition to the metrazol. In these patients insulin was 
added to the treatment because in the early experience of 
giving metrazol alone the authors found that some who 
showed no progreea made prompt improvement when insulin 
was added. The fourth group received insulin in order to 
alleviate the fear of metrazol treatment. In the last 
group metrazol was given after the patients had failed to 
improve on a full course of insulin. 
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Himwioh (53) compares insulin and metrazol therapy. 
He states that a similarity in the two forms of treatment 
lies in the fact that both depress the metabolism of the 
brain, The brain differs from other organs in that it 
uses only oarbohydrates to furnish the en~rgy required. 
lhen hypoglycemia supervenes the brain is therefore de-
prived of its only source of energy. Cerebral metabolism 
is therefore depressed, and under these conditions, first 
excitement and then coma supervenes. Metrazol oonvulsions 
are al~o characterized by depre~sion of the metabolism 
of the brain. '.!'his is not oaused by a diminished dextrose 
uptake but by a decrease in the oxygen supply. During the 
convulsion there is a cessation of respiratory movements 
so that the arterial blood becomes venous and the brain is 
deprived of oxygen. Thus the two treatments have in common 
a depression of cerebral metabolism. Hypoglycemia produoes 
a slow, gradual and prolonged depression. lietra.zol oonTUla-
ions, on the other hand, ca.use a severe deprivation of 
oxygen and therefore.neoessarily must be briefer. The two 
aotions ma7 be combined and they are synergistio. TO the 
slow, gradual hypoglyoemio effect is added the brief, acute 
deprivation of oxygen. It may be ooncluded that the depriv-
ation of cerebral energy is associated with the initiation 
of the changes which oause the amelioration. 
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ES!ROGD 
The mental changes accompanying the menopause may 
be mild or exaggerated. When exaggerated the diagnosis of 
involutional melancholia is made. LStrogen has recently 
been reported of therapeutic value in the treatment of 
these mental aberration oceuring coincident to or follow-
ing the menopause. Ault et al (54) state, "For all pract-
ioal purposes theelin seems to be epeoific in involutional 
melancholia. Theelin is indicated for any woman during 
the olimaoterio having disturbed mental aberration, whether 
mild or severe". Mayer and Israel (55) have applied this 
therapy in a group of patients pre~enting climacteric 
symptoms bordering on involutional melancholia with result-
ing good therapeutic effect. Also Ault and associates (54) 
report that patients institutionalized because of previous-
ly developed mental illness beco~e "disturbed" with the 
advent of the menopause and have quieted down when given 
theelin. Werner et al (56) emphasize that the stresses of 
the menopausal and post-menopausal periods may cause 
dormant psyohotic tendencies to develop into definite 
psyehoses. 'l'hus a schizoid personality, under these cond-
itions, may develop into a typical case of sehizophrenia. 
There are· apparently no aontra-indica. tions to this 
therapy. Werner found that usually only those patients in 
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whom estrogen is being execrated in the urine fail to 
respond to ~heelin therapy; this group comprised not more 
than ten per cent of his oases. Likewise where mental 
deterioration has re9uJ.ted from the long duration of the 
disease process, the prognosis is poor. 
Methods of administration include oral administration, 
hypodermic injections and intramuscular injections. The 
estrogens are available in pure orystalline forms as keto-
hydroxyestrin (theelin) and trihydroxyestrin (theelol). 
The international unit of estrogenio potenoy is the 
effect produoed by 0.1 gamma to.0001 gram) of theelin. 
The relation of animal units to the international unit 
19 quite variable depending upon the manner of bio-assay. 
Mouse units and international units are aooepted as be· 
ing about equal, and a. rat unit 1 a approximately equi Tal-
ent to five interna.tiolUl.l units. {5'7,58) In this paper, 
dosage will be expressed in internation units using the 
above estimations in translating from mouse and rat units. 
The rate of absorption, oontinuity of action, and 
physiologic effect of the estrogens are infleunoed by 
the vehiole used and by the site of injection. Water sol-
uble preparations,whioh are more rapidly absorbed and ex-
ecrated, require more frequent injections and larger 
dosage. Oily solutions are taken up more slowly than 
aqueous golutions. The rate of absorption is more rapid 
from mnsole than from the subcutaneous tissues. 
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Administration of theelol by mouth is praotioal and is 
usually preferred by the patient. It does not, however, 
permit as aoou~ate do~age as does the parenteral route. 
(57) 'heelin in oil is prepared so that 1 oo. contains 
1.0 mg. (10,000 international units) and theelol is pre-
pared so that one oapsule oontains 0.24 mg. (2,500 in-
ternational .ilnite). 
No preoiee rules oan be laid down for dosage or 
methods of treatment, sinoe endoorine imbalance can 
ooour at ¥ery different quantitative levels. Often 
rather small doses of estrogenio subatanoe may be a4-
equate in treating borderline oondit·1ons. (59) Werner 
et al (60) in reporting a series of forty oases of 
involutiona.l melancholia set the dosage at l oo. of the 
aqueous solution (Theelin, Parke Davis, 250 international 
units) daily for six months. They find that the administ~ 
ration of 1 co. of Theelin in 011 (Parke Davis) ~iven 
' -
int:ramusoularly twioe weekly is just as ef'feoti ve ae the c: 
daily dose of l oo. of the aqueous solution also given 
intramu.soularly. Buokle (61) reports a case in which 
PJ?001t0n (Sobering, 225 international units) was administ• 
ered twioe a day per oe. This was increased within a month 
to 1000 international units twice a day. This therapy was 
supplemented by as many as 25,000 international unite of 
eetradiol benzoate as frequently as every week. au.J.t et 
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al (54) reoolDI:lend an initial dosage of from 30,000 to 
40,000 international units of theelin in oil in all typee 
of oases during the first month. This ean be conveniently 
divided into doses of 5000 units of theelin in oil intra-
musoularly, twice weekly. Subsequent dosage was adjusted to 
meet the patients needs. Fluhman has injeoted as m&Il7 as 
20,000 units every three or four days for several weeks. 
(62) Werner in a reoent article (63) reoommends a larger 
dose of from 1000 to 2,000 units of estrogenic hormone ae 
often as three times a week, and,in some cases, as muoh 
as 2,000 units daily during.the first month with subsequ-
ent reduction. As soon as an unmistakable response is 
obtained, the dosage may be gradually reduoed, but theelin 
administration should probably be continued for several 
weeks after adjustment has apparently been made and rec-
overy from the psyohosis taken place. Werner et al (60) 
and Suoklei (61) advise a c'ouree of intensive therapy. 
Werner et al (60) consider six: months necessary for a 
therapeutic test of the efficacy of theelin in individual 
oases. Only by observing the patient when treatment has 
been discontinued is it pos9ible to determine when theelin 
may be permanently discontinued. In a series of fourteen 
institutionalized ca9es, Ault et al report definite improve-
ment in two ca9e9 as early as one oonth following institut. 
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ion of theelin therapy, and slight improvement in a third. 
In only four patients was treatment continued beyond three 
months. Of these three were treated for· six months, and 
one was treated for ten months • .All four were reported as 
showing marked improvement. It has been suggested that 
theelol per os be administered during the process of 
theelin withdrawal after menopausal and mental symptoms 
have been brought under control. It is also advooated 
as supplementary to intramuscular therapy. As much as 
2 mg. per day may be administered. 
Ault et al (54) report a recovery rate of ninety 
two per oent in their series of oases. Mazer and Israel 
report a series of thirty three borderline oases, all of 
whioh responded to estrogenio therapy irregardless of 
the severity of the symptoms. Werner et al (56) report 
a serie$ of forty patients. Twenty of these were given 
loo. of theelin in aqueous solution intramuscularly 
daily for six months. The other twenty oases were used 
as oontrola and were given l oc. of physiologic sodium 
chloride intramusoularly daily for the same period of 
time. After the control patients had failed to benefit 
by the injeotions of physiologio sodium chloride, they 
were given 1 oo. of theelin intra.musoularly daily for 
six months. 
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In the first twenty patients treated with theelin, 
marked improvement was shown in 61.9%, moderate improve~ 
ment in 14.2" and no improvement in 9.5~. In the control 
patients marked improvement was shown in no oase, moderate 
improvement was shown in 10.5~ and no improvement in 84.2%. 
In these control patients, after receiving theelin, marked 
improvement was shown in 44.4~• moderate improvement in 
27.7~. In this control group involutional melancholia 
oomplioated by other forms of mental disease was present 
in 27 .7%. 
B7 marked improvement these workers assume that the 
patient has recovered sufficiently to lead normal social 
live9. Of the total group, these workers report a marked 
improvement in 65.55%. (56) 
These authors believe that with continued therapy 
the group showing moderate improvement will oontinue to 
improve. They al~o advocate the administration of theelin 
in oil intramuscularly (l oo. i. e. 1500 llllita) weekl7 
for an extended time after the preliminary treatment to 
prevent relapse in patiente whose syndrome will be of long 
duration. After disoontinuanoe of medioation it should be 
promptly reestablished in the faoe of a relapse. (56) 
Werner et al (56) oonolude that theelin in ourative 
in oases of unaomplioated involutional melancholia. that 
theelin aoolerate9 reoovery and shortens the period of 
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ment&l illnees, that the yroeno~is iq favorahly 1nfleuno-
e4 by early diagnosis and treatment, that a history of 
previous mental disorder in the patient suggests a guar4-
ed prognosis, and that the ad?!linistration of theelin may 
be used as a therapeutic diagnostic test to differentiate 
between involutional melancholia and other types of mental 
disease oocuring at the menopause. 
The rationale of 'this. therapy is somewhat problemat-
io. :l!1 luhman ( 64} uota<i th6't following the a.uterior hypo-
, • ,r 
{ 
physis hypertrophies and that there i" an, increase in 
the amount of gonadotr,pio hormone-in the .~lood serum 
of many of these women, Maser and Goldstein t65) note 
that the ovarian follicular hormone, estrogen, on the 
other hand decreases. Werner et al (60) state that 
during the menopause there is a complex endocrine orisie 
in which the predominati-ng :feature is gonadal insuffio-
ienoy, and that other glandular disturbances ooour sub-
sequently and form an essential part of the complex. 
This 1nclude9 imbalanoe in other interrelated glende euoh 
as the anterior lobe of the pituitary, the thyroid, and 
the adrenal~ He etate9 that mo9t of the symptoms are a 
result of the instability of the autonomic nervous 
system resulting secondarily from the disturbanoe of the 
endocrine glands. 
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BENZEDRINE 
:Ben3edr1ne, beta.-amino-prophylbenzene or benzyl-
methyl oarbinamine, ha9 been found to posses~ a sympatho-
mimetic action and a profound stimulating eff eot on the 
oentral nervous system. It has been found to have an 
ameliorative infleunoe in oertain conditions inoluding 
ohronio exhauetion (66,67,68), disorders of mood and 
affect (66,67,68,69,70,71), certain oases of psycho-
neurosis (68), and naroolapsy (67). The drug apparently 
is of little value in schizophrenia including oatatonia 
states and hebephrenia. It is probable that eventually 
benzedrine will be found to have its greatest value in 
the treatment of chronic exhaustion or depression when 
it is used temporarily or perhaps intermittently. ( 66) 
Wilbur et al (66) report that the iilll:lediate effects of 
the oral administration of benzedrine in cases of chronic 
exhaustion, depression and psychoneurosis were benefioiil 
to approximately eighty, seventy and forty six per aent 
of the aa~e~ re~peatively. Prinzmeta1 and Bloomberg (72) 
9tate that benzedrine is approximately three times as 
effeotive as ephedrine in preventing attaoks of sleep in 
naroolep9y, and that in some oases it gives complete 
relief of symptoms that are not relieved by huge dosee 
of ephedrine. 
89 
There appear to be but few definite oontra-indioat-
ions to benzedrine therapy. When symptoms auoh as nervoua-
ness, anxiety, restlessness and irritability are present 
they are frequently wiinfleunoed or even accentuated. 
Wilbur et al state that the drug does not appear to be 
toxio in usual doses and that it does not seem to be habit 
forming. A• to the continued use of this drug they are 
lees optimistic. It is their opinion that it is unwise to 
reoommend the continuous use of benzedrine except to 
patients who are less than sixty years of age, who present 
no evidence of hypertension or oardiao disease and who 
oan be olosely watched by the physician. They report that 
in patients guffering from psychoneurosis with dominant 
symptoms of nervousness and anxiety, inability to relax 
and laok of energy, the symptoms are aaoentuated by the 
administration of benaedrine. Beoause of this they do not 
recommend the prolonged administration of benzedrine to 
this group. Likewise Apfelberg (73) reports a oase of 
benzedrine poisoning in a psyohoneurotio and Anderson 
and Saott (74) desoribe a aase presenting very 9eVere 
oardiovasoular symptom9 in a patient with involutional 
depression following benzedrine therapy.(66) 
Wilbur et al (66) reporting a series of one hundred 
patients diagnosed as chronic exhaustion, psychoneurosis, 
and depression used an initial oral dose of benzedrine 
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sulfate ranging from two and one-half to twenty milli-
grams before breakfast, repeating the dose at noon if 
neoessary. The usual dose ranged from ten to twenty milli-
grams. They report that if the drug is taken later than 
noon, insomnia usually results. It is their experience 
that if the condition of the patient fails to improve 
following the administration of one of the doses noted 
he will not be lenefited by a larger amount of the drug. 
Likewise the effect of benzedrine therapy will be as 
pronounced on the first day a's 1 t will be on subo:Jequent 
days. Thus the effeot'3 of its adminic:itration oan "be 
determined in one day. If there is no beneficial effect 
from its admin~strati0n before breakfast and lunoh on one 
day, it appears useless to administer it over longer 
periods. Many of the patients with exhaustion and depress-
ion whom they have observed and who have taken benzedrine 
over a period of weeks or months have found that they were 
able to reduoe the dose to a~ little as from two and one-
half to fiva milligrams before bre~kfast, with oontinua.t-
ion of good results. In other oases ten milligrams in 
the morning and from two and one-half to five milligrams 
at noon will maintain a favorable effeot. Oooaeionally 
patients find that intermittent use of the drug provee 
more satisfactory than continuous administration. 
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Solomon et al (75) have given as muoh as 160 mg. a day, 
apparently in divided doses, for three weeks, without 
apparent hannful effeot. Davidoff and feifenstein (76) 
have administered 200 mg. in one day to a patient with-
out a resulting 9evere reaction. Prinzmetal and Bloom-
berg (72) in the treatment of naroolepsy with bensedrine 
used doses varying from ten to forty milligrams three 
times daily depending upon the age of the patient and 
the severity of the disease. Peoples and Guttmann (77) 
gave doses of from ten to eighty milligrams to twenty 
five persons noting usually a rise in blood pressure 
and pulse rate with no other oardiovaaoular phenomena. 
Hartung and Munoh (78) find that the minimum lithal dose 
of benzedrine hydrochloride is twenty five milligrams 
per eaoh kilogram of body weight of rats. 
Although benzedrine has an apparently large pharm-
aoo logioal margin of safety, it must not be inferred 
that its administration is not attended without toxio 
manifestations. Suoh manifestations ae oardiovasoular 
disturbances, exhaustion and fainting or else collapse 
have been noted in the more severe reaotione. (73)The 
oase of benzedrine poisoning reported by Ap.felberg (73) 
demonstrates that the drug may beaome lethal, at least 
' 
in some individuals, in .far smaller doses than those 
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oomputed by experimental ratios deducted from its effects 
on animals. In this caee, the patient, diagnosed as a 
psyohoneurotio, had evidently taken 140 mg. of benzedrine 
in a single dose. Upon arrival at the hospital he was in 
a oo:r.iatose state from which he could not be aroused. Prior 
to admission the family had noted loss of sphincter control 
and the occurrence of several convulsive attaoks. Upon 
admission to the hospital the patient was in a oondition 
of shook; the s~:ein was a'3hy pa.le, the extremities cold and 
clammy, the pulse was not perceptible, the oardiao rate 
was sixty, and the blood pres'3Ure wae 100/70. The temp• 
erature was 94.4 F. and the re~piratory rate varied between 
eighteen and twenty four. Tremor of the upper extremities 
and fibrillary twitchings of the muscles of the jaw were 
observed together with a Babinski sign on the right and 
a Hoffman sign on the left. The pupils were mid-wide and 
equal and reacted to light. There was no nystag:mus. The 
patient recovered from coma about thirty six hours after 
admission but was mildly confused, retarded, and depressed 
for a day, after whioh mental olearness continued. So.b~ 
sequently, following a course of stomatitis, hematuria, 
and pneumonia, the patient made a oomplete recovery within 
ten days following admission. (73} Anderson and Soott 
describe a case presenting very severe oardiovascular 
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symptoms following the use of thirty milligrams of 
benzedrine sulfate. This patient, who was suffering from 
1nvolut1onal depres91on with paranoid ideas, became 
dyspneic and !lushed two and one-half hours after bemsedr-
ine was taken. Several hours attar that the~e was aollapee 
oyanosis, ola.rmniness and a slowing of the pulse rate to 
fifty six with a lapse of every fourth beat. In reviewing 
the literature they state that nowhere else did they 
find '!UOh severe oardiovasoular effeote. 
Myereon (68) has ma.de a study of the effects of 
benzedrine sulfate on mood and fatigne in normal and in 
neurotic persons. He states that the normal non-psyohotio 
and non-neurotic persons who suffer from fatigu.e and 
slight malaise due to insufficient rest receive immediate 
benefits and relief of a pleasant type when from five to 
twenty milligrams of benzedrine sulfate is taken on aris-
ing. Bradley (80) states that the result is felt within 
thir.ty to forty fl ve minutes and the maximum reaotion 
occurs during the second or third hour following the 
administration. He states that within sixteen hours there 
is complete subsidence of the effect of this drug. Myer-
eon states that a dose of from five to twenty milligrams 
taken by mouth causes a warm glow which is agre•able and 
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which is associated with a sense of relaxation and at the 
same time result9 in the disappearanoe of the tired feel-
ing around the face and eyes. Aooording to hi.m, the effeot 
la9ts from two to several hours. With a larger dose the 
subject may feel "jittery", and may have a sense of over-
tension and excitability. 
The reaction, in patients diagnosed as ohronio ex-
haustion, is variable. In some instances it resulted in 
a complete disappearance of exhua9tion, marked exhilar-
ation and inorea9ed capacity for physical and mental work. 
Along with this there were, in some cages, extraversion 
of thought and activity, syeeding up of ~antel proce~ses, 
oheerfulne9s, elation and loquaciousness. Vague neuro-
muscular aohes and pains and consciousness of abdominal 
discomfort frequently ware greatly benefited or entirely 
relieved. When symptoms such a9 nervousness, anxiety, 
re9tlessness and irritability were present they were 
frequently uninfleunoad or even accentuated. 1.Iany of the.se 
patients stated that they felt "jittery" or stimulated 
and that they noted dryness of the mouth, palpitation, 
tremor and excessive sweating. In etates of depression 
the patients become happy and confident and there wae an 
increase in psychic and motor activity. 
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Wilbur et al (66) in their series of one hundred 
oases olassified their patients as: first, chronic ex-
haustion, characterized by persistent sensations of fatigue, 
laok of energy and lassitude for whioh no organic oause 
oan be demonstrated; second, psyohoneurosie, oharaoterized 
by nervousness, anxiety, restlessness, irritability, in-
ability to relax, and numerous somatic symptoms in whioh 
fatigue is not a prominent symptom, and third, depression 
with mental and physical slowing being the pr4dominant 
feature of the clinical picture. All of these patients 
were carefully examined and had no detectable evidence 
of organic disease. They report that in cases of ohrnoio 
exhaustion forty eight per cent of the oases are continu-
ing to use benzedrine after periods of from one to eight 
months and feel that the favorable effects have persisted. 
Twenty two per cent felt improved during the use of this 
drug for from one week to one month, but disoontinued its 
use beoau9e unpleasant effects noted previously continued, 
and offset the benefioial results. Improvement of the 
oondition of thirty µer cent of the~a oa9es continued for 
from three weeks to four months while they used the drug, 
but they discontinued the use of it after variable periods 
because improvement was only slight, beoa.U'9e of subsequent 
development of undesirable symptoms or because the effeot 
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ot the drug wore off entirely. A review of the record$ 
of the patients whose oondition was improved and of those 
for whom improvement was only temporary or was associated 
with unpleasant symptoms failed to reveal any distinguish• 
ing features that oould be used to explain the divergent 
results. It may be inferred that idiosynorasias to small-
er doses and also resistance to larger doses in this oond-
i tion is apparently a factor infleunoing the psychosomatic 
reactions in different individuals. In the patients 
diagnosan as psychoneurosis, prolonged administration 
of benzedrine was discontinued as many of these patients 
noticed that unpleasant symptoms of this condition were 
accentuated by the administration of the drug. If exhaust-
ion was present, frequently it was improved, but the 
dominant symptoms were frequently exaggerated. Likewise 
in the group ola'!sified as depressions the results of the 
prolonged admini9tration of benzedrine were disappoint-
I 
ing. Of the9e oases twenty four per cent had used the 
drug for six months and continued to obtain relief. Five 
per cent obtained relief for from three to six months. 
Fourteen per cent obtained relief for three months. Twenty 
eight per cent obtained relief for one month and another 
twenty eight per cent obtained relief for only one week. 
Thus it is obvious that relief of depression as a result 
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of the administration of benzedrine is te~porary in many 
instanoes. The treatment i'3 variable with each patient, 
some patients receiving marked benefit from prolonged 
administration in which 1m~tance9 its use should be 
continued. 
The results of the prolonged administration of 
benzedrine are more encouraging. It should be mentioned 
that the olaS<Jifioat ion of this syndror.:ie of sonu1olenoe, 
and cataplexy as a neurosis is at the present time debat-
able. Recent observers believe that actual pathological 
changes are present. (79) The first patient with narool-
epsy to whom Prinzmetal and Bloomberg ( 72) reported gi v-
ing the drug has continued taking the same dose of the 
drug after three years. They conolude from their series 
of ca9e9 that in all in ".!tance s oor1plete relief from 
the attacks of sleep and practically complete relief of 
oataplexy results when 9Uitable doses of benzedrine aTe 
given. ":'hey find that. on the averr~ge, tJ:is compound is 
three timee as effective a9 ephedrine. They have observed 
no diminution in the effectiveness of benzedrine when 
given over comparativaly long periods of time. 
The results of the prolonged administration of benzedr· 
ine have been discussed with relation to duration of 
treatment. The imr:1ediate effects are more encouraging. 
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Wilbur et al (66) report that the immediate e:r:feots o:f 
the oral administration of benzedrine in their series 01· 
one hundred oa'3es were beneficial in eighty per cent of 
the patients suffering from chronic exhaustion, in seventy 
per cent of those with depression and in forty six per 
oent of those suffering with psychoneurosis. Of the patients 
initially benefited about fifty per cent of those who had 
chronic exhaustion and about twenty five per oent of those 
who had depression continued to receive benefits for 
periods of from one to eight months. 1!yerson ( 68) states 
that in certain ca'3es of the neurosis a'.3socia.ted with 
depression, fatigue and anhedonia, and in certain oases 
of the minor stages of the psychosis of the sace general 
type, benzedrine acts as an ameliorative infleunoe. ne 
states that as it helps to dissipate the morning apathy 
and depression its ameliorative efiect ie sufficiently 
important to recommend it during the treatment of the 
patient by other means and while the process of natural 
recovery is taking place. In his opinion benzedrine does 
not fundamentally and pennanently alter a psychotic dis-
order or a state of chronic exhaustion. it is not in any 
sense curative and its effects are not permanent. 
1·he toxic manifestations, that may result following 
the administration of benzedrine have already been 
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dieoussed. Un:favorable gastro-intestinal symptoms 
inoluding abdominal cramps and an increased desire to 
go to the stool have also been noted.(76) Loss of 
weight, apparently resulting from reduced appetite and 
increased aotivity,may ooour.(66,67,76) 
The method by which benzedrine produces a stimulating 
aotion on the oentral nervous system and the part of the 
brain it stimulates is unknown. Marked stimulation of 
the nervous system is the most striking effect of the 
drug. ~he long duration of the effect is noteworthy. 
Wilbur et al state that while it appears to them that 
in states of exhaustion benzedrine may simply decrease 
awareness of fatigue, they are uncertain whether this 
is the result of stimulation of the oentral nervous 
system or of sympathomimetio activity. (66) It is evident 
that its action is that of ~timUlation. Whether it is 
logical and safe to oontinuously stimulate individuals 
who present such disturbances is a question that has not 
been answered as yet. It should be kept in mind that it 
is possible that the abolishment of the sensation of 
fa~igue and exhaustion may result in the expenditure of 
energy beyond the oapaoity of the individual. 
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With mental patients oaoupying fifty five per cent 
of all available hospital beds in the United States, 
with the inoidenoe of potential mental disease in the 
United States being placed at one in every twenty six 
individuals, and with functional mental disorders con-
stituting forty six per cent of all forms of mental 
illness, the treatment of these functional disorders 
is assuming great importance. 
Of equal signifioanoe is the fact that with modern 
methods of therapy between sixty five and seventy five 
per cent of the9e patients may recover. The paramount 
importanoe of the early institution of therapy in these 
conditions is evidenced by the oonparison of recovery 
rates of acute and ohronio oases. It may be concluded 
that the rate of remission and the degree of recovery 
is inversely proportional to the duration of the ill-
ness. 
Within the last deoade drug therapy as adjunots in 
the treatment of thege patients was instituted. Insulin 
in shook producing amounts and metrazol were found to 
be of value in the sohizophrenio group of psyohoses; 
rnetra.zol and carn"!"lhor were found to be of value in the 
depressive states and in oertain of the psyohoneuroses; 
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estrogenio substanaes were found to be of value in the 
treatment of involutional melanoholia and benzedrine 
was found to be of value in treating narcolepsy and 
certain of the psyohoneurosis. 
It wag not the authors intention to imply medical 
therapy to be the panacea of fu.notional mental disease. 
That these methods may serve as valuable adjunots in 
the treatment of these patients is evidenced by the 
statistics furnished. 
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